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Deutsche Zusammenfassung
Proteine sind nicht nur grundlegende Bausteine unserer Zellen, sondern auch verant-
wortlich fu¨r die Katalyse der meisten Reaktionen die unser Leben ausmachen. Auf-
grund ihres einfachen Aufbaus aus nur zwanzig verschiedenen Aminosa¨uren und der
trotzdem hohen Variabilita¨t in Gro¨ße, Form und Funktion sowie der gut skalier-
baren Produktion in Bakterien haben Proteine aber auch ideale Voraussetzungen
um gerichtet Katalysatoren fu¨r chemische Prozesse zu konstruieren. Hierbei sind
besonders zwei Gebiete von Interesse: Das Design von Proteinfaltungen sowie das
Design neuer Aktivita¨ten.
Ein Teil der vorgestellten Arbeit bescha¨ftigt sich mit dem Design eines de novo
TIM-barrels, der wohl wichtigsten Faltung fu¨r Enzyme. Dieses Projekt entstand aus
einer Zusammenarbeit mit Possu Huang und der Arbeitsgruppe von David Baker an
der Universita¨t Washington, Seattle. Verschiedene Designs, welche nach gemeinsam
festgelegten Prinzipien von Possu Huang am Computer generiert worden waren,
wurden dabei von mir charakterisiert. Eine Variante kristallisierte und lieferte eine
Kristallstruktur die den Erfolg des Designs besta¨tigte. Diese Ergebnisse wurden
Anfang des Jahres in Nature Chemical Biology publiziert [1].
Der zweite Teil bescha¨ftigt sich mit dem rationalen Design einer neuen enzyma-
tischen Aktivita¨t basierend auf der klassischen katalytischen Serintriade. Mehrere
Proteinstrukturen wurden mittels Computer-gestu¨tzter Suche als mo¨gliche Tra¨ger
der Triade identifiziert und basierend darauf verschiedene Varianten mit optimierten
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Bindungstaschen in silico konstruiert und evaluiert. Die Konstrukte wurden im La-
bor hergestellt und analysiert. Eine Variante zeigte eine schwache katalytische Ak-
tivita¨t. Diese Variante wurde hinsichtlich Struktur und Funktion im Detail charak-
terisiert.
Diese beiden komplementa¨ren Studien, die beide versuchen die Grenzen des
Computer-gestu¨tzten Design der Form und Funktion von Proteinen zu erweitern,
tragen bei zu einem besseren Versta¨ndnis von Proteinsequenz-, Struktur- und Funk-
tionsbeziehungen.
Chapter 1
Introduction
1.1 Understanding life
Modern multicellular organisms like ourself have always been in the focus of human
research. However our emphasis over the history of natural sciences shifted with the
progress of methods and technical possibilities. Early approaches tried to explain
the machine of life on a macroscopic level, discovering the major building parts, the
organs, and their function. The development of the microscope led to discoveries
that left the boundaries imposed by our naked eye. Suddenly structures present
at a microscopic level were visible and could be characterized (e.g. Antonie van
Leeuwenhoek, 17th century). It took another two hundred years until the rise of
organic chemistry made it possible to address the question of what makes life work
at an even smaller level, leading to discoveries that extended our understanding of
the mechanisms involved to a molecular and atomic level.
In the last century this molecular understanding was led to new heights with
the description of structures of two of the most important and complex classes of
macromolecules in our cells: DNA, which stores the cells information, and proteins,
the molecules responsible for most of the work necessary to keep us alive.
9
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1.2 Proteins
What is fascinating about proteins is that in contrast to their wide variety in form,
function and size they all derive from a few small building blocks, the amino acids. In
most organisms there are only twenty different amino acids, and during the expres-
sion of a protein these small building blocks are connected through peptide bonds,
forming a long linear string. It is the sequence of the string that is determined by the
gene responsible for the expression of a particular protein, and it is this mechanism
that is responsible for the usage of the vast majority of information stored in the
DNA.
What happens next upon expression is coarsely described as protein folding:
According to the physical and chemical properties of the different amino acids at
different positions, the protein folds into a stable, three dimensional structure that
will be the same for every newly expressed protein of this type. It is the combination
of amino acid sequence and structure that determines what this proteins function
will be, whether it will be a part of the cells skeleton, an enzyme degrading food
or a receptor for insulin. Therefore, if we want to understand proteins, we have to
understand protein folds and protein folding.
1.3 Protein structure
There are different levels of protein structure. The most basic one is the sequence
of amino acids forming a specific protein, which has accordingly been named the
primary structure of proteins.
Depending on the sequence, even small fragments of proteins can fold into what
is called secondary structure. There are two major types of secondary structure,
the α-helix and the β-strands (see figure 1.1). In α-helices the amino acids form a
helix with roughly 3.6 amino acids per turn, stabilized by hydrogen bonds within
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the backbone atoms. Within β-strands the amino acids lie flat to each other, with a
characteristic zigzag pattern where every amino acid points in the opposite direction
as its two neighbors. Several β-strands placed in a plane can form what is known
as a β-sheet by interactions between the backbone atoms of neighboring strands.
Different secondary structure elements are connected by so called loops, often quite
flexible stretches of amino acids.
Figure 1.1: The two basic secondary structure elements of proteins: The α-helix
on the left where amino acids form a helix stabilized by hydrogen bonds between
backbone atoms. The other element is the β-strand on the right, where amino acids
form a plane. Several (in this case parallel) β-strands form a β-sheet stabilized by
hydrogen bonds between backbone atoms of neighboring strands. In both cases the
Cβ atoms carrying the side chains are colored Grey.
Build from these secondary structural elements, proteins fold into a stable three-
dimensional structure and for some proteins like the ones responsible for a cell’s cy-
toskeleton, this structure is already their purpose, using their shape to give structure
and stability to the cell. However, in many cases proteins have other functionalities
such as the very important function of a chemical catalyst, namely enzymes.
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1.4 Enzymes
If life is seen as the complex system of reactions that makes cells thrive, grow
and multiply, then enzymes are its basis. Although there are indications that in
early lifeforms catalysts were based on RNA [2], by now most reactions in cells are
catalyzed by proteins.
In the case of a catalyst a certain structure alone is of course not sufficient for
function, it has to be combined with a binding pocket where the substrates interact
and a specific chemical environment depending on the reaction that is catalyzed.
A scaffold where these two different necessities, a stable structure and an active
center, can be observed and even nicely structurally separated is the TIM-barrel
scaffold (see figure 1.2). This scaffold is named after the triose phosphate isomerase
where it was first discovered, however by now a wide variety of TIM-barrels has
been described. It is not only the most variable enzyme scaffold (of the six enzyme
classes TIM barrels are found in five, only lacking a member with ligase activity)
but also a very old one. Members catalyze reactions that are central to modern
living organisms, the already mentioned triose phosphate isomerase serves as a good
example. What is quite remarkable in TIM-barrels is the separation of structure
and activity. The core of the protein, build by a central barrel formed by eight β-
strands and surrounded by eight α-helices is quite rigid and responsible for the overall
stability of the enzyme. The functional groups are in all members, as different as
their reactions are, localized on top of the barrel, either at the end of the β-strands,
or in the loops connecting them.
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Figure 1.2: The TIM-barrel structure, arguably the most important scaffold for
enzymes, is build up by elternating β-strands and α-helices. It shows a clear dis-
tinction between the main barrel which contributes stability to the scaffold and the
top of the barrel which caries the different catalytic activities (catalytic residues are
shown in pink). Shown here is the structure from the name-giving triose phosphate
isomerase (PDB ID: 1TIM [3]).
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The active centers themselves, however, are as diverse as the reactions they cat-
alyze. As with all enzymes, they have to provide two main functions: A pocket that
is likely to specifically bind the substrate and keep it in place during the reaction,
and the catalytic center composed of amino acids or cofactors creating a chemical
environment that leads to catalysis. While the first part strongly depends on the
substrate and can vary greatly within very similar reactions, the catalytic part is of-
ten very similar within analog catalysts even if they do not share a common origin.
Many of these widespread mechanisms have been analyzed quite thoroughly, and
among the best understood and most famous catalytic motifs is that of the catalytic
serine triad, one of the textbook examples of enzyme mechanisms.
1.5 The catalytic triad
Considering that the catalytic triad is a surprisingly small motif, it is capable of
performing quite difficult reactions such as the hydrolysis of peptide bonds. It
consists of three amino acids forming the name-giving acid-base-nucleophile triad
and sometimes in addition one or more nitrogen atoms forming what is called the
oxyanion hole. Probably due to its simplicity it evolved several times independently
[4], usually within hydrolases or transferases. A variety of different triads are known
today [5] with the classic one consisting of serine as the nucleophile, histidine as the
base and aspartate as the acid.
These three amino acids have to be present in a very specific geometry (see figure
1.3), allowing them to form a charge-relay system that allows the nucleophile (usually
serine or cysteine) to be activated and attack covalent bonds. The mechanism
that leads first to the cleavage of the substrate and later to the restoration of the
catalytic triad is complex and consists of several steps. After said nucleophilic
attack in which a charged intermediate is stabilized by the oxyanion hole, a first
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tetrahedral intermediate is formed by formation of a covalent bond between parts
of the substrate and the nucleophile. The first product leaves after addition of a
hydrogen from the base (histidine in the classic example). Said nucleophile is later
restored, for example by hydrolysis of the second product.
Figure 1.3: The catalytic triad as found in trypsin is comprised of a serine, a histidine
and an aspartate. While the serine and histidine usually point to the substrate
binding pocket, the acid can be buried within the enzyme. The blue balls represent
the two backbone nitrogen atoms forming the oxyanion hole. PDB ID: 4MTB.
The number of different substrates that are processed by catalytic triads is huge.
Enzymes utilize this same motif for different reactions by combining it with different
scaffolds and binding pockets, leading to a variety of highly efficient and often very
specific catalysts. And while enzymes catalyze a large variety of reactions for natural
substrates, this mechanism should also be able to catalyze hydrolysis of substrates
that might not be present in Nature yet still be beneficial for us. So the question
is, with the amount of knowledge available, are we able to design whatever enzymes
we might need?
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1.6 Enzyme design
Just like natural enzymes need both a stable fold and a specific catalytic center,
we need the ability to predict and design both if we want to create completely new
enzymes with new activities. Both sides of enzyme design were in the focus of
research for decades.
De novo design of a TIM-barrel
Designing a certain structure is not only important for the design of enzymes, but
for the design of other protein-based tools like biosensors as well. In the past years
several attempts were made to design folded proteins de novo [6] [7] [8]. Among
the approaches more relevant to enzyme design, the de-novo design of a TIM-barrel
has been in the focus of scientists for at least 25 years [9] and has been ongoing
for a while [10] [11] [12] [13] [14]. The structure of TIM-barrels seems to be simple
and natural variants often show a high stability. Nevertheless, up to now there was
no confirmed de novo designed variant where the design could be confirmed with a
structure. While early designs even seemed to lack secondary structure, the latest
variants seem to be folded at least on the level of secondary structure. However,
attempts to derive a structure, the crucial proof that the design goal was met,
remained futile.
In collaboration with Possu Huang and David Bakers group we decided to at-
tempt yet another trial in the race for the first successful TIM-barrel design, trying
to deliver the proof that by now we are able to engineer the most widespread and
important enzyme scaffold. The results are described in chapter 4.
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Rational design of a new hydrolase
The design of enzymatic function, however, had quite some successful examples in
the past years. Thus far there has been a variety of different reactions successfully
engineered into proteins, such as Retro-Aldol reactions [15] [16], Kemp-elimination
[17] [18], Morita-Baylis-Hillman [19] and Diels-Alder reactions [20] (see [21] for an
overview). There were also of course attempts to incorporate the classic catalytic
triad into a new scaffold [22] [23], however a complete and enzymatically active
catalytic triad has not yet been engineered. Doing so would actually serve a dual
purpose: On the one hand it would proof that our understanding of one of the
best known catalytic motifs is thorough enough to be used as a template for design.
On the other hand a successful design should be able to catalyze reactions such
as the breakage of peptide bonds. Compared to prior designed enzymes, this is
a quite difficult multistep reaction which requires a high activation energy to be
overcome. The required geometry necessary for this reaction shows - compared with
most geometries used for earlier designs - little margin for error, putting a lot of
emphasis on the selection and design of protein scaffolds chosen to become enzymes.
Due to both its importance as a showcase example for enzymes and the fact
that a successful design would proof that also the engineering of energetically more
difficult reactions in enzymes is within our reach, I attempted to computationally
design a catalytic triad based catalyst. The approach and its results are described
in chapter 5.
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Chapter 2
Material
2.1 Equipment
Shaker
• Innova 411 (Eppendorf)
• Multitron II (Infors)
Centrifuges
• Centrifuge 5810R (Eppendorf)
• Centrifuge 5424 (Eppendorf)
• Heraeus Fresco 17 (Thermo Scientific)
• Avanti J-26xPI (Beckmann Coultier)
Thermocycler
• MyCycler Thermocycler (BioRad)
• T3000 (Biometra)
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Scales
• 572 (Kern)
• Fine scale ALS120-4 (Kern)
Chromatography
FPLCs
• AEkta Pure 25M (GE Healthcare)
• AEkta P900 (GE Healthcare)
• AEkta Prime (GE Healthcare)
Columns
• HisTrap HP, 5ml (GE Healthcare)
• HisTrap HP, 1ml (GE Healthcare)
• Superdex 75 10/300 GL (GE Healthcare)
• HiLoad Superdex 75 PG (GE Healthcare)
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Spectrometer
• Avance III NMR spectrometer 800MHz (Bruker)
• FP-6500 fluorescence-spectrometer (Jasco)
• J-810 CD-spectrometer (Jasco)
• ND-1000 Nanodrop (PeqLab)
• Cary 50 Scan UV-VIS spectrometer (Varian)
Crystallization
• Honeybee 963 crystallization robot (Genomic Solutions)
• Mosquito crystallization robot (TTP)
• Rock Imager 182 Imaging System with UV optics (Formulatrix)
Other Equipment
• digital sonifier W-250 (Branson)
• pH211 microprocessor pH meter (Hanna)
• Thermoblock (Olaf Waase)
• miniDAWN TREOS Multi-Angle Light Scattering Detector (Wyatt tech-
nology)
• Micropulser electroporator (Biorad)
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2.2 Enzymes
• FD NdeI (Fermentas/Thermo Scientific)
• FD XhoI (Fermentas/Thermo Scientific)
• FastAP (Fermentas/Thermo Scientific)
• Taq polymerase (Fermentas/Thermo Scientific)
• Q5 High fidelity DNA Polymerase (New England Biolabs)
• T4 ligase (New England Biolabs)
2.3 Chemicals
Loading dyes and size standards
• Gene ruler 50bp (Fermentas/Thermo Scientific)
• Gene ruler 100bp (Fermentas/Thermo Scientific)
• Gene ruler 1kbp (Fermentas/Thermo Scientific)
• loading dye (6) for DNA electrophoresis (Fermentas/Thermo Scientific)
• 2x SDS samplebuffer 100mM TRIS pH 6.8, 20 % Glycerol, 4 % SDS, 0.2M
DTT and a spatula tip of Bromphenol blue
• Unstained Protein Molecular Weight Marker (Thermo Scientific)
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Various compounds
• Phenylmethylsulfonyl fluoride (PMSF) CAS: 329-98-6 (Sigma-Aldrich)
• 4-(2-Aminoethyl)benzensulfonylfluorid (AEBSF) CAS: 30827-99-7 (Sigma-
Aldrich)
• 5,5-Dithiobis-2-nitrobenzoic acid (DTNB) CAS: 69-78-3 (Sigma-Aldrich)
• L-Alanine 4-nitroanilide hydrochloride (ApNA) CAS: 31796-55-1 (Sigma-
Aldrich)
• N-Benzoyl-L-tyrosine p-nitroanilide (YpNA) CAS: 6154-45-6 (Sigma-
Aldrich)
• Val-Ala p-Nitroanilide acetate salt (VApNA) CAS Number 108321-94-4
(Sigma-Aldrich)
• N-Succinyl-Ala-Ala-Pro-Phe p-nitroanilide (AAPF-pNA) CAS: 70967-
97-4 (Sigma-Aldrich)
• 4-Nitrophenyl acetate (pNAc) CAS: 830-03-5 (Sigma-Aldrich)
• Dithiothreitol (DTT) (Roth, No. 6908.2)
• Coomassie Staining Solution 400ml water, 400ml ethanol, 1g Coomassie
Blue G-250
2.4 Purification kits
• NucleoSpin Gel and PCR Clean-up (Macherey-Nagel)
• NucleoSpin Plasmid EasyPure (Macherey-Nagel)
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2.5 Bacterial growth media
• LB Medium For 1l: 10g pepton from bacteria, 5g NaCl, 5g yeast extract
• TB medium For 1l: 24g yeast extract, 12g tryptone, 4ml glycerol, 2.31g
KH2PO4, 12.54g K2HPO4
• Autoinduction medium 50ml 20x NPS, 20ml 50x5052, 1ml MgSO4, ZY
medium ad 1l
– 20x NPS 6.6g (NH4)2SO4, 13.6g KH2PO4, 14.2g Na2HPO4, water ad
100ml
– 50x 5052 25g glycerol, 10g α-lactose, 2.5g glucose, water ad 100ml
2.6 Vectors
• pet21a(+) (Novagene), Ampicillin resistance
• pet29b(+) (Novagene), Kanamycin resistance
2.7 Software
• ScaffoldSelection [24]
• Rosetta 3.3-3.5 [25]
• Pymol The PyMOL Molecular Graphics System, Version 1.7 Schrdinger,
LLC.
• XDS [26]
• Phenix suite [27]
2.7. SOFTWARE 25
• Ape-A Plasmid Editor (M. Wayne Davis)
• Ugene [28]
• Spectrum Manager 5 (Jasco)
• Gimp 2.8
• Mendeley
• TeXstudio
• Bioinformatics toolkit [29]
• Blender Blender - a 3D modeling and rendering package
• FROG2 [30]
• CLANS [31]
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2.8 Sequences
3N8M
10. 20. 30. 40. 50.
3N8M MIEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKF 50
3N8M3x ...............h...d.............................. 50
3N8M_R16H ...............h.................................. 50
3N8M_E20D ...................d.............................. 50
3N8M_H55S .................................................. 50
3N8M_R16H_H55S ...............h.................................. 50
3N8M_E20D_H55S ...................d.............................. 50
3N8M_varA ...............h...d...l..........f...ry..y.i.a... 50
3N8M_varB ...............h...d...l..........f...wy..y.i.a... 50
3N8M_varC ...............h...d..............f...ry..y.i.a... 50
3N8M_varD ...............h...d..............f...wy..y.i.a... 50
60. 70. 80. 90. 100.
3N8M GNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDI 100
3N8M3x .....s............................................ 100
3N8M_R16H .................................................. 100
3N8M_E20D .................................................. 100
3N8M_H55S .....s............................................ 100
3N8M_R16H_H55S .....s............................................ 100
3N8M_E20D_H55S .....s............................................ 100
3N8M_varA .....s.l.......................................... 100
3N8M_varB .....s.l.......................................... 100
3N8M_varC .....s.l.......................................... 100
3N8M_varD .....s.l.......................................... 100
110.
3N8M EQVPQQPTYVQAHHHHHH 118
3N8M3x .................. 118
3N8M_R16H .................. 118
3N8M_E20D .................. 118
3N8M_H55S .................. 118
3N8M_R16H_H55S .................. 118
3N8M_E20D_H55S .................. 118
3N8M_varA .................. 118
3N8M_varB .................. 118
3N8M_varC .................. 118
3N8M_varD .................. 118
Figure 2.1: Sequences of the constructs utilizing the scaffold of 3N8M, a human
Grb2 SH2 Domain.
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3N8M alternative insertion site
10. 20. 30. 40. 50.
3N8M_wt MIEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKF 50
3N8M_alt_varA ........q......d...h..........................h.f. 50
3N8M_alt_varB ........n......d...h...........h..a...........y.f. 50
3N8M_alt_varC ........n......d...h...........a..s...........y.w. 50
60. 70. 80. 90. 100.
3N8M_wt GNDSQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDI 100
3N8M_alt_varA .yr.yq............................................ 100
3N8M_alt_varB ..n.kr.r.......................................... 100
3N8M_alt_varC ..r.yr............................................ 100
110.
3N8M_wt EQVPQQPTYVQAHHHHHH 118
3N8M_alt_varA .................. 118
3N8M_alt_varB .................. 118
3N8M_alt_varC .................. 118
Figure 2.2: Sequences of the constructs utilizing the scaffold of 3N8M, a human
Grb2 SH2 Domain, with an alternative insertion site. Selection of these variants
was done together with Marcel Conrady, who also cloned the constructs.
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1W54
10. 20. 30. 40. 50.
1W54 MSFTPANRAYPYTRLRRNRRDDFSRRLVRENVLTVDDLILPVFVLDGVNQ 50
1W54_3x .................................................. 50
60. 70. 80. 90. 100.
1W54 RESIPSMPGVERLSIDQLLIEAEEWVALGIPALALFPVTPVEKKSLDAAE 100
1W54_3x .................................h................ 100
110. 120. 130. 140. 150.
1W54 AYNPEGIAQRATRALRERFPELGIITDVALDPFTTHGQCGILDDDGYVLN 150
1W54_3x ........................s......................... 150
160. 170. 180. 190. 200.
1W54 DVSIDVLVRQALSHAEAGAQVVAPSDMMDGRIGAIREALESAGHTNVRIM 200
1W54_3x .................................................. 200
210. 220. 230. 240. 250.
1W54 AYSAKYASAYYGPFRDAVGSASNLGKGNKATYQMDPANSDEALHEVAADL 250
1W54_3x .................................................. 250
260. 270. 280. 290. 300.
1W54 AEGADMVMVKPGMPYLDIVRRVKDEFRAPTFVYQVSGEYAMHMGAIQNGW 300
1W54_3x .................................................. 300
310. 320. 330.
1W54 LAESVILESLTAFKRAGADGILTYFAKQAAEQLRRGR 337
1W54_3x .....................d............... 337
Figure 2.3: Sequences of the constructs utilizing the scaffold of 1W54, a Porpho-
bilinogen Synthase from Pseudomonas aeruginosa.
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2D52
10. 20. 30. 40. 50.
2D52_wt MSSLSNSLPLMEDVQGIRKAQKADGTATVMAIGTAHPPHIFPQDTYADVY 50
2D52_3x .................................................. 50
2D52v2 .............................t.................... 50
2D52_v3 .............................t.................... 50
2D52_v4 .............................t.................... 50
2D52_v5 .............................t.................... 50
2D52_v6 .................................................. 50
2D52_v7 .................................................. 50
2D52_v8 .................................................. 50
2D52_alt3x .................................................. 50
60. 70. 80. 90. 100.
2D52_wt FRATNSEHKVELKKKFDHICKKTMIGKRYFNYDEEFLKKYPNITSYDEPS 100
2D52_3x .................................................. 100
2D52v2 .................................................. 100
2D52_v3 .................................................. 100
2D52_v4 .................................................. 100
2D52_v5 .................................................. 100
2D52_v6 .................................................. 100
2D52_v7 .................................................. 100
2D52_v8 .................................................. 100
2D52_alt3x .............................s..h...d............. 100
110. 120. 130. 140. 150.
2D52_wt LNDRQDICVPGVPALGTEAAVKAIEEWGRPKSEITHLVFCTSCGVDMPSA 150
2D52_3x ..........................s.h...d................. 150
2D52v2 ..........................s.h...d................. 150
2D52_v3 ..........................s.h...d................. 150
2D52_v4 ..........................s.h...d................. 150
2D52_v5 ..........................s.h...d................. 150
2D52_v6 ..........................s.h...d................. 150
2D52_v7 ..........................s.h...d................. 150
2D52_v8 ..........................s.h...d................. 150
2D52_alt3x .................................................. 150
160. 170. 180. 190. 200.
2D52_wt DFQCAKLLGLHANVNKYCIYMQGCYAGGTVMRYAKDLAENNRGARVLVVC 200
2D52_3x .................................................. 200
2D52v2 ............................................v..... 200
2D52_v3 ............................................a..... 200
2D52_v4 ............................................v..... 200
2D52_v5 ............................................a..... 200
2D52_v6 ............................................v..... 200
2D52_v7 ............................................a..... 200
2D52_v8 ............................................v..... 200
2D52_alt3x .................................................. 200
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210. 220. 230. 240. 250.
2D52_wt AELTIMGLRAPNETHLDNAIGISLFGDGAAALIIGSDPIIGVEKPMFEIV 250
2D52_3x .................................................. 250
2D52v2 ..........................................a....... 250
2D52_v3 ..........................................g....... 250
2D52_v4 ..........................................g....... 250
2D52_v5 ..........................................a....... 250
2D52_v6 ..........................................a....... 250
2D52_v7 ..........................................g....... 250
2D52_v8 ..........................................g....... 250
2D52_alt3x .................................................. 250
260. 270. 280. 290. 300.
2D52_wt CTKQTVIPNTEDVIHLHLRETGMMFYLSKGSPMTISNNVEACLIDVFKSV 300
2D52_3x .................................................. 300
2D52v2 .................................................. 300
2D52_v3 .................................................. 300
2D52_v4 .................................................. 300
2D52_v5 .................................................. 300
2D52_v6 .................................................. 300
2D52_v7 .................................................. 300
2D52_v8 .................................................. 300
2D52_alt3x .................................................. 300
310. 320. 330. 340. 350.
2D52_wt GITPPEDWNSLFWIPHPGGRAILDQVEAKLKLRPEKFRAARTVLWDYGNM 350
2D52_3x .................................................. 350
2D52v2 .................................................. 350
2D52_v3 .................................................. 350
2D52_v4 .................................................. 350
2D52_v5 .................................................. 350
2D52_v6 .................................................. 350
2D52_v7 .................................................. 350
2D52_v8 .................................................. 350
2D52_alt3x .................................................. 350
360. 370. 380. 390. 400.
2D52_wt VSASVGYILDEMRRKSAAKGLETYGEGLEWGVLLGFGPGITVETILLHSL 400
2D52_3x .................................................. 400
2D52v2 .................................................. 400
2D52_v3 .................................................. 400
2D52_v4 .................................................. 400
2D52_v5 .................................................. 400
2D52_v6 .................................................. 400
2D52_v7 .................................................. 400
2D52_v8 .................................................. 400
2D52_alt3x .................................................. 400
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410.
2D52_wt PLMLEHHHHHH 411
2D52_3x ........... 411
2D52v2 ........... 411
2D52_v3 ........... 411
2D52_v4 ........... 411
2D52_v5 ........... 411
2D52_v6 ........... 411
2D52_v7 ........... 411
2D52_v8 ........... 411
2D52_alt3x ........... 411
Figure 2.4: Sequences of the constructs utilizing the scaffold of 2D52, a Pentaketide
chromone synthase from Aloe arborescens.
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2cfm
10. 20. 30. 40. 50.
2cfmwt MRYLELAQLYQKLEKTTMKLIKTRLVADFLKKVPDDHLEFIPYLILGEVF 50
2cfm3x .................................................. 50
2cfm3x+F318I .................................................. 50
2cfmv12 .................................................. 50
2cfmv34 .................................................. 50
2cfmv1314 .................................................. 50
2cfmv12_268R .................................................. 50
2cfmv12_268C .................................................. 50
2cfmv12_530R .................................................. 50
2cfmv12_533K .................................................. 50
60. 70. 80. 90. 100.
2cfmwt PEWDERELGVGEKLLIKAVAMATGIDAKEIEESVKDTGDLGESIALAVKK 100
2cfm3x .................................................. 100
2cfm3x+F318I .................................................. 100
2cfmv12 .................................................. 100
2cfmv34 .................................................. 100
2cfmv1314 .................................................. 100
2cfmv12_268R .................................................. 100
2cfmv12_268C .................................................. 100
2cfmv12_530R .................................................. 100
2cfmv12_533K .................................................. 100
110. 120. 130. 140. 150.
2cfmwt KKQKSFFSQPLTIKRVYQTLVKVAETTGEGSQDKKVKYLADLFMDAEPLE 150
2cfm3x .................................................. 150
2cfm3x+F318I .................................................. 150
2cfmv12 .................................................. 150
2cfmv34 .................................................. 150
2cfmv1314 .................................................. 150
2cfmv12_268R .................................................. 150
2cfmv12_268C .................................................. 150
2cfmv12_530R .................................................. 150
2cfmv12_533K .................................................. 150
160. 170. 180. 190. 200.
2cfmwt AKYLARTILGTMRTGVAEGLLRDAIAMAFHVKVELVERAYMLTSDFGYVA 200
2cfm3x .................................................. 200
2cfm3x+F318I .................................................. 200
2cfmv12 .................................................. 200
2cfmv34 .................................................. 200
2cfmv1314 .................................................. 200
2cfmv12_268R .................................................. 200
2cfmv12_268C .................................................. 200
2cfmv12_530R .................................................. 200
2cfmv12_533K .................................................. 200
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210. 220. 230. 240. 250.
2cfmwt KIAKLEGNEGLAKVQVQLGKPIKPMLAQQAASIRDALLEMGGEAEFEIKY 250
2cfm3x .................................................. 250
2cfm3x+F318I .................................................. 250
2cfmv12 .................................................. 250
2cfmv34 .................................................. 250
2cfmv1314 .................................................. 250
2cfmv12_268R .................................................. 250
2cfmv12_268C .................................................. 250
2cfmv12_530R .................................................. 250
2cfmv12_533K .................................................. 250
260. 270. 280. 290. 300.
2cfmwt DGARVQVHKDGSKIIVYSRRLENVTRAIPEIVEALKEAIIPEKAIVEGEL 300
2cfm3x ..................s............................... 300
2cfm3x+F318I ..................s............................... 300
2cfmv12 ...f..............s............................... 300
2cfmv34 ...n..............s............................... 300
2cfmv1314 ...n..............s............................... 300
2cfmv12_268R ...f.............................................. 300
2cfmv12_268C ...f..............c............................... 300
2cfmv12_530R ...f..............s............................... 300
2cfmv12_533K ...f..............s............................... 300
310. 320. 330. 340. 350.
2cfmwt VAIGENGRPLPFQYVLRRFRRKHNIEEMMEKIPLELNLFDVLYVDGQSLI 350
2cfm3x .................................................. 350
2cfm3x+F318I ..................i............................... 350
2cfmv12 .................................................. 350
2cfmv34 .................................................. 350
2cfmv1314 ..................i............................... 350
2cfmv12_268R .................................................. 350
2cfmv12_268C .................................................. 350
2cfmv12_530R .................................................. 350
2cfmv12_533K .................................................. 350
360. 370. 380. 390. 400.
2cfmwt DTKFIDRRRTLEEIIKQNEKIKVAENLITKKVEEAEAFYKRALEMGHEGL 400
2cfm3x .................................................. 400
2cfm3x+F318I .................................................. 400
2cfmv12 .................................................. 400
2cfmv34 .................................................. 400
2cfmv1314 .................................................. 400
2cfmv12_268R .................................................. 400
2cfmv12_268C .................................................. 400
2cfmv12_530R .................................................. 400
2cfmv12_533K .................................................. 400
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410. 420. 430. 440. 450.
2cfmwt MAKRLDAVYEPGNRGKKWLKIKPTMENLDLVIIGAEWGEGRRAHLFGSFI 450
2cfm3x .................................................. 450
2cfm3x+F318I .................................................. 450
2cfmv12 .................................................. 450
2cfmv34 .................................................. 450
2cfmv1314 .................................................. 450
2cfmv12_268R .................................................. 450
2cfmv12_268C .................................................. 450
2cfmv12_530R .................................................. 450
2cfmv12_533K .................................................. 450
460. 470. 480. 490. 500.
2cfmwt LGAYDPETGEFLEVGKVGSGFTDDDLVEFTKMLKPLIIKEEGKRVWLQPK 500
2cfm3x .................................................. 500
2cfm3x+F318I .................................................. 500
2cfmv12 .................................................. 500
2cfmv34 .................................................. 500
2cfmv1314 .................................................. 500
2cfmv12_268R .................................................. 500
2cfmv12_268C .................................................. 500
2cfmv12_530R .................................................. 500
2cfmv12_533K .................................................. 500
510. 520. 530. 540. 550.
2cfmwt VVIEVTYQEIQKSPKYRSGFALRFPRFVALRDDKGPEDADTIERIAQLYE 550
2cfm3x ..............................d..h................ 550
2cfm3x+F318I ..............................d..h................ 550
2cfmv12 ..............................d..h................ 550
2cfmv34 ..............................d..h................ 550
2cfmv1314 ..............................d..h................ 550
2cfmv12_268R ..............................d..h................ 550
2cfmv12_268C ..............................d..h................ 550
2cfmv12_530R .................................h................ 550
2cfmv12_533K ..............................d................... 550
560.
2cfmwt LQEKMKGKVESHHHHHH 567
2cfm3x ................. 567
2cfm3x+F318I ................. 567
2cfmv12 ................. 567
2cfmv34 ................. 567
2cfmv1314 ................. 567
2cfmv12_268R ................. 567
2cfmv12_268C ................. 567
2cfmv12_530R ................. 567
2cfmv12_533K ................. 567
Figure 2.5: Sequences of the constructs utilizing the scaffold of 2cfm, a DNA Ligase
from Pyrococcus furiosus.
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Methods
3.1 Cloning
Introduction of mutations
Mutations were introduced using primers with the desired sequence and creating
fragments utilizing outside primers and the corresponding mutation primers. The
fragments were used as templates in a subsequent amplification by PCR [32] utilizing
only the outside primers. The program is as follows:
98◦C 30 sec
98◦C 10 sec
55◦C 20 sec
72◦C 20 sec
72◦C 5 min
× 30 cycles
Colony PCR
Colony PCRs were performed to identify correctly cloned variants. Single colonies
were picked from a LB plate and used to inoculate a 5ml overnight culture in LB
with the appropriate antibiotics as well as a template for a colony PCR. The tip of
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the pipet used for colony picking was therefore dipped into 20µl of PCR mixture
containing 2× 1µl of primer, 200µM of dNTP mix, 2µl of TAC buffer, 1.5mM of
MgCl2, 2 units of Taq polymerase and water up to the final volume. The mixture
was put into a thermocycler and the according PCR program was run:
95◦C 5 min
95◦C 20 sec
55◦C 20 sec
72◦C 30 sec
72◦C 5 min
× 30 cycles
After the reaction finished, the solution was spun down in a tabletop centrifuge and
loaded onto an agarose gel.
Agarose gel electrophoresis
Agarose gels between one and two percent were used to separate DNA fragments of
different lengths. The DNA - together with SYBR green dye - was loaded into the
pockets of the gel and roughly 70V of voltage were applied. After the electrophoresis,
blue light was used to detect the position of the DNA bands. Pictures were taken
under UV light.
Plasmid extraction
Plasmids were extracted from 5 ml over night cultures. The cells were spun down by
centrifugation (10min, 4000rpm). The plasmids were purified with the NucleoSpin
Plasmid EasyPure kit from Machery-Nagel.
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DNA digestion and ligation
DNA fragments were digested with the appropriate enzymes in 1 × Fast Digest
buffer. Vector digestions were additionally treated with fastAP. FastAP is a phos-
phatase, dephosphorylating the ends of the plasmid, thus preventing religation. Lig-
ation took place in 20 µl of total volume with a mixture of digested fragment and
vector, 1× fresh ligation buffer and 200 units of T4 DNA ligase. The reaction was
left for one hour at room temperature or - for higher efficiency - at 4◦C over night.
The reaction as a whole was transformed into chemically competent cells. The cells
were plated, grown and single colonies were picked and used for further testing.
Sequencing
50 ng of DNA template were mixed with 2 µl of sequencing buffer, 0.5µl of BDT
mix and primer to a final concentration of 1µM. Water was added to a volume of
10µl and the reaction was put on a thermocycler utilizing the sequencing program:
96◦C 20 sec
50◦C 10 sec
60◦C 4 min
× 30 cycles
The samples were then brought to our in-house sequencing service and the resulting
sequences were analyzed.
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Competent cells
Chemically competent cells
For chemically competent cells, 400ml of LB medium was inoculated with 4ml of
overnight culture and grown at 37◦ C until the OD600 reached 0.5. The cells were
centrifuged for 15min at 4000rpm and 4◦ C. The pellet was then resuspended in
20ml cooled 100mM CaCl2. The cells were again centrifuged as before and the
pellet resuspended in 2ml 100mM CaCl2, 15% glycerol. Aliquots of 100µl were
frozen and stored at -80◦C.
Electrocompetent cells
50ml of LB medium was inoculated with 0.5ml overnight culture and grown at 37◦C
until the OD600 reached 0.6. The culture was then cooled on ice for 30min followed
by centrifugation at 4000rpm, 4◦C for 10min. The pellet was resuspended in cold,
sterile water and incubated on ice for 15min. The centrifugation, resuspension and
incubation on ice steps were repeated several times while the resuspension volume
was decreased to 20ml, 10ml and finally 1ml. Aliquots of 100µl were frozen and
stored at -80◦C.
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Transformation
Heat shock transformation of chemically competent cells
Chemical competent cells were thawed on ice for five minutes. Plasmid was added
to the cells, mixed and incubated for ten minutes. The mixture was then heated to
42◦C for 45 seconds (20 seconds if E. coli Arctic ExpressTM was used) and put back
on ice for an additional ten minutes. After that 900µl of LB medium was added
to the mixture and the bacteria were incubated for one hour at 37◦C while shaking
gently. This micro culture was then used to inoculate a culture with medium and
antibiotics according to the plasmid used (100µg/ml for Ampicillin and 50µg/ml for
Kanamycin) or plated onto a petri dish with LB and antibiotics.
Transformation of electrocompetent cells
The sample containing the plasmid was dialysed on distilled water for 15min to
remove salt. The cells were mixed with the sample and incubated on ice for 10min.
The mixture was put into a chilled GE Healthcare Gene Pulser cuvette and inserted
into the electroporator. The program EC2 was chosen and the charge was released.
900µl LB were added to the cells and incubated at 37◦C for 1h. The cells were then
plated onto a petri dish with LB and the appropriate antibiotics.
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3.2 Protein expression and purification
Expression
For expression a small preculture was grown over night in the according medium
and with antibiotics present. 5-10ml of that preculture were used to inoculate 2 l
of medium in a 5 l Erlenmeyer flask. The cultures were grown at 37◦C shaking
at 180rpm until an OD600 of 0.8 was reached. The shaker was set to expression
temperature and expression was induced by addition of 2 ml 1M IPTG. After a
certain time dependent on the construct expressed (4 hours for 2cfm and 3N8M,
around 14 hours for the other scaffolds), the cells were harvested by centrifugation
for 12min at 4000rpm. The pellet was washed in 40 ml of buffer usually consisting
of 150mM NaCl and 50mM potassium phosphate buffer at pH8. If the protein was
used for crystallization the potassium phosphate buffer was substituted with 50mM
TRIS buffer. The cells were again centrifuged at 4000rpm for 15min and the cells
were then solubilized in a buffer dependent on the construct used and the experiment
planned (in most cases 150mM NaCl, 50mM potassium phosphate buffer or TRIS
if the protein was used for crystalization. There were two exceptions: For the early
round of 3N8M designs the pH was set to 7.5, while for the 2D52 variants 100mM
NaCl, 50mM HEPES pH 7 was used).
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Cell rupture by sonication
E. coli cells from 2l of expression were resuspended in 40ml buffer and poured into a
50ml falcon tube. These volumes were adjusted for larger expression volumes. The
tube was put into a beaker filled with water and ice and placed under the sonifier.
Sonification took place for ten minutes at an amplitude of 45% and with a pulse
sequence of 1:2 pulse:pause (usually 1s:2s).
Freeze/thaw lysis
Freeze/Thaw lysis was used as a high throughput method for lysing of small volumes
of many constructs in parallel. The cells were mixed with buffer to a final volume
of 1ml and poured into 1ml eppendorf tubes. The tubes were closed and repeatedly
frozen in liquid nitrogen followed by immediate thawing in warm water. Depending
on the experiment, at least five cycles were applied.
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Purification
Affinity chromatography
The basis of separation in this method is the affinity of different compounds to
the matrix of the column. For the proteins purified in this work, a C-terminal tag
consisting of six histidines was added. This leads to a strong affinity towards metals
such as cobalt or in our case Nickel which was attached to the sepharose resin.
Size exclusion chromatography
Size exclusion chromatography or gel filtration is a chromatographic technique sep-
arating chemical compounds such as proteins according to their physical size. Sep-
aration takes place in a column filled with an adsorbent material. Particles of this
material have pores of a defined diameter on their surface. Depending on the size of
the protein it will enter such pores with a certain probability and if a flow is applied
to the column thus remain longer in the stationary phase. Larger compounds will
have a smaller probability to enter these pores and therefore remain longer in the
mobile phase. If a mixture of proteins is loaded onto the column larger proteins will
therefore elute first.
Using the elution time of certain standard proteins with known masses, one can
obtain a characteristic curve for a given column (see Figure 3.1) and can use the
elution time of a protein to estimate its mass or - for proteins with known mass -
its oligomerization state.
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Figure 3.1: Example for a calibration curve of a size exclusion column, in this case an
analytical Superdex 75. The magenta line represents the void volume of the column.
The black line is the linear regression of the results from the calibration proteins.
Here the LMW gel filtration calibration kit from GE Healthcare was used in several
consecutive gel filtration runs, resulting in datapoints for ribonuclease A (13.7 kDa),
carbonic anhydrase (29kDa), ovalbumine (44kDa) and conalbumine (75kDa). The
void volume was determined with blue dextran 2000.
3.3 Protein characterization
Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis is a method to determine the amount and size
of different protein compounds in a mixture. The protein mixture is heated to 95
◦C for 5 min in the presence of Sodium dodecyl sulfate (SDS). SDS attaches to the
protein, both denaturing it up to the point where it is present in a linear shape as
well as leading to a homogeneous negative surface charge. The linearized fragments
with the attached charged SDS is then loaded onto a polyacrylamide gel and a
current is applied. The charged fragments now move to the anode with a speed
that is dependent on the size of the linearized proteins and smaller proteins moving
faster than large proteins. The current is stopped before the smallest proteins reach
the border of the gel and protein bands are stained with coomassie blue followed
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by destaining in warm water or 10% acetic acid. The protein size corresponding to
positions of certain bands can then be determined by comparison with a standard
mixture of proteins with defined and known masses.
Multiangle light scattering
Multiangle light scattering (or MALS) makes use of different scattering characteris-
tics of a protein sample in solution. Since the amount of scattering strongly depends
on the (known) wavelength and the size of the particles in solution, this can - un-
der the assumption that the particles are spherical [33] - be used to determine the
particles average size. Experimentally, we used an analytical gel filtration column
to separate possibly different protein populations. The MALS measurements were
done in real time directly after the column. A tight laser beam is send through a
measurement cell with the filtered eﬄux of the gel filtration column. Light scattering
is then measured at a variety of different angles from the measuring cell.
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Circular dichroism
In order to determine the amount and type of secondary structure present in a
protein, UV circular dichroism measurements can be utilized. Circular dichroism
describes a property of many chiral substances. If a solution of an optical active
chiral molecule is measured with left- and right handed polarized light there will
be a difference in absorption dependent on the wavelength and properties of the
molecule (see figure 3.3). The difference between absorption at a given wavelength
is measured in degrees of ellipticity (see figure 3.3). In a circular dichroism spectrum,
this ellipticity is measured for a range of wavelengths and plotted against them.
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Figure 3.2: Graphical illustration of the measure of ellipticity θ used to compare the
secondary structure content of different proteins
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Figure 3.3: Typical CD spectra of different secondary structure content. Solid line:
α-helix, coarse dashes: β-sheet, points: β-turn and fine dashes: random coil. From
Johnson, W C, Protein secondary structure and circular dichroism: a practical guide.
Proteins, 1990, Vol. 7 Issue 3 p. 205-214
For protein solutions, unordered structure and loops as well as α-helices and β-
sheets will show specific circular dichroism spectra in the far UV region. Depending
on the form of the spectrum one obtains from a protein solution, it is possible to
estimate the amount of secondary structure present and thus have an estimate of
the amount of folded protein [34] [35].
If not specified, all samples were measured at room temperature in a 1mm cuvette
in a J-810 CD-Spectrometer (Jasco).
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Melting curves
Proteins are stable only within a certain temperature range and most in fact unfold
in aqueous solution before the boiling point of water is reached. The thermal stability
is an important factor and determines sample handling as well as the possibility to
perform certain experiments such as NMR. In order to compare different proteins
with different melting characteristics, the melting point is introduced and defined
as the temperature where half of the protein is still in a folded state.
Experimentally the melting point is determined by heating up a protein sam-
ple at a constant rate (usually 1◦C per minute) while continuously measuring the
change in circular dichroism at a wavelength that shows a large change upon un-
folding (for proteins with a strong α-helical content this is usually at 222nm). The
result for a single step unfolding will ideally be a sigmoid curve, which is partially
constant in both the lower (colder) region and the upper (hotter) region resembling
the completely folded and completely unfolded state. The melting point is then
the temperature where the plot passes the arithmetic mean of the CD signal of the
folded and unfolded state.
Tryptophan fluorescence
The indole ring of tryptophan has a strong fluorescence when excited with a wave-
length of 280nm. Typically emission is measured between 300 and 400nm. Trypto-
phan is a solvatochromic fluorophore, which means that it changes both its emission
maximum and its intensity dependent on the polarity of its environment. Trypto-
phans within folded proteins are often buried in the hydrophobic core. However,
upon unfolding they will be exposed to solvent, leading to an increasingly polar en-
vironment. Changes in tryptophan fluorescence can therefore be utilized to monitor
loss of tertiary structure within a protein.
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If not specified, all samples were measured in a 1cm cuvette in a FP6500 fluo-
rescence Spectrophotometer (Jasco) at 25◦C.
Chemical denaturation and Gibbs energy
There are a variety of compounds that have the ability to denature folded proteins,
leading to a loss of structure. Among these are reagents that change the pH or
organic solvents. The changes in secondary and tertiary structure can be measured
using CD spectroscopy and tryptophan fluorescence. Two of the most common
denaturants are urea and guanidinium hydrochloride. They belong to the group of
chaotropic agents, signifying that they increase entropy and in high concentrations
lead to the disruption of hydrogen bonds as well as van der Waals interactions.
Since the destabilizing effect of these reagents is nearly linear to its concentration,
titration experiments can be used to determine the actual stability of a protein
by calculating the difference in Gibbs energy between the folded and the unfolded
state [36].
Figure 3.4: Determination of the fraction of unfolded protein from an unfolding
curve. From [37], page 302
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In order to do so the signal for a completely folded and a completely unfolded
protein is determined and all measurements are normalized according to these values
resulting in a plot signifying the fraction of folded protein at a given concentration
of denaturing agent. The change in Gibbs energy is then calculated based on a
concentration range where the plot is both linear and at its steepest (see figure
3.4). For every point in this range, the change in Gibbs energy at the according
concentration of denaturand is calculated as
∆G = −RT lnK
where R is the gas constant, T the temperature of the sample and K the fraction
of unfolded/folded protein. The different ∆G values are then plotted against the
concentration of denaturing agent and extrapolated to the y-intercept resembling a
concentration of no chaotropic reagent. The energy at this point gives the change
in Gibbs energy upon unfolding (see chapter 4, figure 4.16).
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NMR
Nuclear magnetic resonance spectroscopy uses the spin of atomic nuclei to determine
their state. Atoms where the sum of protons and neutrons is odd have a spin that
can with a certain probability be aligned in a magnetic field. The fraction of atoms
where this alignment takes place is dependent on the strength of the magnetic field
applied with stronger fields resulting in better alignment and higher signal. Using
electromagnetic pulses one can now induce rotation into the spin axis of the aligned
nuclei. Depending on the frequency of the pulse, different nuclei can be induced
specifically. The rotation and its decay over time can be measured. This so called
free induction decay is different for atoms in different environments. In this work
one dimensional 1H NMR was used to determine the presence of tertiary structure in
proteins which results in specific peaks in the Fourier-transformed NMR spectrum.
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X-ray crystallography
In this chapter I give a short introduction to x-ray crystallography. In general, this
is based on ’Biomolecular Crystallography’ by Rupp [38].
A short introduction
In a crystal lattice the elements forming the crystal (in our case proteins) are ar-
ranged in a symmetric, periodic way. For this introduction into the classification
of crystal lattices let us assume that we have an infinite lattice L in R consisting
of copies of a protein. We then define the unit cell U as the (by volume) smallest
periodic subset of L. The size of U is described by the length of the edges.
For the tetragonal-trapezohedral cells in this work all three edges are orthogonal
to each other. In general there are several possible unit cells which depend on the
space group. For the trivial space group p1 every translation of a unit cell is again a
unit cell which results in an infinite amount of possible unit cells. This example also
demonstrates that in general it is not necessary to have a complete and connected
structure within a single unit cell. It is sufficient to have a complete and connected
structure in our unit cell when we identify each edge with its parallel counterpart
resulting in a topology equivalent to that of a 3-torus or R3/Z3 (see figure 3.5).
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Figure 3.5: Example for the topology of a two dimensional unit cell. On the left a
possible representation with the center marked by a black dot. In a crystal lattice
this specific arrangement is repeated in all four directions of the crystal plane. Ele-
ments on the top of the arrangement are therefore close to elements at the bottom
of the next repeat. In a unit cell representing the crystal lattice, the upper edge is
therefore identified with the bottom edge, which leads to the topology of a cylinder
(middle) by basically ’gluing’ the edges together. For the same reason the right edge
of the unit cell is identified with the left edge, and subsequently the right edge of the
cylinder is identified with the left edge. Gluing these edges together leads to a torus
topology (right). Three dimensional unit cells are in a similar way topologically
equivalent to a 3-torus.
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Point groups
Crystals lattices are classified according to their point groups. For a given unit cell
the according point group P is defined as the set of all isometries I on R that leave
the center c of the unit cell fixed, so
P := {i ∈ I : i(U) = U , i(c) = c}
Since the unit cell is unchanged, the lattice is also invariant under the isometries of
the unit cell. In a three dimensional space there are 32 different point groups.
Space groups
The space group S of a certain unit cell is the set of isomorphisms that map the
unit cell on itself, so
S := {i ∈ I : i(U) = U}
Every space group can also be written as the combination of a point group with the
set of discrete translations of a Bravais lattice. The set of point groups can therefore
also be seen as the quotient of the set of space groups by the set of Bravais lattices.
This immediately introduces a classification of the space groups according to the
point group they relate to. Therefore, point groups are also called crystal classes.
In a three dimensional space there are 230 different space groups. Determination of
the correct space group is one of the first necessary steps in order to obtain a crystal
structure and was in this work done with XDS [26].
Experimental setup
Protein samples were concentrated as high as possible. For each sample, Qiagen
NeXtal screens were set up in 96 well sitting drop plates. The drop consisted of 0.5µl
of protein sample and 0.5µl of screening buffer. The setup was pipetted automat-
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ically with either the honeybee or mosquito robot by Sooruban Shanmugaratnam.
The plates were stored at 20◦C and imaged regularly. Grown crystals were fished
(if necessary with additional cryoprotectant such as PEG400) and frozen in liquid
nitrogen.
All spectra of proteins were recorded at the Swiss Light Source of the Paul
Scherrer Institute in Villigen/Switzerland. For this work we used the PXII (X10SA)
beamline. The defaults of the measurements are given in the appropriate tables
under results.
Determination of space group and unit cell
Before beginning the actual structural work, it is necessary to determine the actual
crystal lattice present and describing it in terms of its unit cell as well as its space
group. This work was done using the XDS suite [26].
Molecular replacement
Since X-ray crystallographic spectra recorded with usual sensors only contain inten-
sities (∼ amplitude) and no phase information, it is impossible to directly calculate
the corresponding electron density [39]. However, since the spectra should equal the
Fourier transform of the electron density, the measured intensity of the spectrum
can be compared with the amplitude of the Fourier transformed electron density.
Historically this has been done with Patterson maps, however, in this work I used
phaser utilizing a more modern method based on a maximum-likelihood estimation
of the electron density. In all cases one has to give a reference structure that is used
as a basis for the estimations. This reference should be as similar as possible to the
expected structure and show no large rearrangements. Since the structure in the
unit cell is yet unknown at the state of molecular replacement, great care should be
used not to bias a possible solution too much with the reference. I therefore used
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reference structures consisting only of the protein backbone and rejected solutions
not showing density fitting the side chains of the newly build model.
Model building
Once an initial model is build by molecular replacement, it has to be optimized
and arranged according to the density obtained. This was done alternating manual
model building and optimization in coot and refinement with phenix.refine from the
phenix suite vs 1.9-1692 [27]. Parts where the initial model was obviously wrong
(often loops with a low density and high B values) were removed and as far as
possible rebuild manually into the visible density. Also sidechains that were placed
yet had no density justifying their placement were deleted.
The weights for the different optimization steps in phenix.refine were mostly
chosen manually and often changed during the process of building a final model in
order to address the problems most pressing at the given time.
The model was determined sufficient based on a variety of parameters, most
notably the Rfree and Rwork but also the B factors, deviations from ideal bond
angles and lengths, calculated clashscores and the occurance of ramachandran and
rotamer outliers.
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Mass spectrometry
Mass spectrometry is used to measure the charge to mass ratio of either complete
proteins or fragments. For this work two different methods have been used.
Matrix-assisted laser-desorption/ionisation time of flight (MALDI-TOF)
measurement
For this measurements a protein is mixed with another compound, the so called ma-
trix, and quickly co-precipitated. The mixture is ablated with a laser and the ionized
particles are accelerated through a vacuum tube. The time of flight t corresponds
to the mass m and the charge z:
t ∼
√
m
z
Measuring the position of different peaks in counts/t, it is possible to determine the
absolute mass of the protein used.
Electrospray ionization Mass spectrometry (ESMS)
In contrast to MALDI, electrospray ionization works with liquid protein solutions
by charging the solution in a capillary until it is turned into an aerosol at the end of
the capillary by electrospray. In contrast to MALDI this technique is more gentle,
leading to less fragmentation of large macromolecules such as proteins.
Tryptic digest
It is possible to digest proteins of interest with proteases such as trypsin before mass
spectrometry and measure the fragments obtained from this digestion. This can be
used to identify proteins by comparing the spectra obtained with a calculated spec-
trum that would be expected for a certain protein digested with certain proteases.
It is also possible to locate modifications of the protein more precisely by identifying
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the fragments that show a mass shift relating to a particular modification.
3.4 Enzymatic activity assays
In order to measure enzymatic activity, chromophoric substrates were used (see fig-
ure 3.6). The typical test consisted of 100µM of substrate (usually a p-nitroanilide
derivate) and 0.1 mg of purified protein in a buffer depending on the construct (usu-
ally NaCl and either potassium phosphate or TRIS buffer at pH 7.5 or pH 8.0). The
reaction volume was 1ml and reactions took place in either a glass or single-use plas-
tic cuvette. Since the released 4-nitroaniline has a much higher absorption at 410 nm
than the uncut substrate (see figure 3.7) in aqueous solution, changes in absorption
were measured at this wavelength. The reactions were followed spectroscopically for
several hours in a Cary 50 Scan UV-VIS spectrometer. Additionally, spectra were
recorded before and after the measurements to detect unspecific changes in the ab-
sorption such as precipitation of the protein or fogging of the cuvette. The reaction
temperature was set to constant 20 or 25◦C. Since especially the ester substrates,
but to a lower degree also the peptide substrates showed a high autolysis in aqueous
solution, measurements included the substrate without protein as a standard.
Enzymatic turnover speeds were derived from the changes in absorption and used
to calculate parameters such as kcat or kM .
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Figure 3.6: Alanine-p-nitroanilide or ApNA, the substrate used in the design study.
Product formation can be followed at 410nm.
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Figure 3.7: Comparison of the spectra of 100µM ApNA and 100µM 4-nitroanilide.
At 410nm ApNA has a very low absorption, while 4-nitroanilide and thus the cleaved
product shows a strong absorption.
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3.5 Inhibition assays
There are a variety of known inhibitors of the catalytic serine triad. In this work
both PMSF and AEBSF were used. The mechanism of inhibition is the same for
both compounds. Activated serines from catalytic triads will cleave fluor from the
inhibitor and form a covalent bond analogous to the first tetrahedral intermediate
of the reaction. In contrast to the substrate the inhibitor is not released, and by
occupying the active oxygen of serine the triad is not active any more (see Figure
3.8).
serine OH + F S
O
O
NH2
HF
serine S
O
O
NH2
Figure 3.8: Inhibition of the catalytic triad with AEBSF. The compound functions
as a substrate analog up to the point where the tetrahedral intermediate is formed.
Upon formation of the first tetrahedral intermediate the reaction stops and the serine
is covalently bound to the inhibitor, rendering the triad nonfunctional.
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Chapter 4
De-novo design of a TIM-barrel
4.1 Introduction
TIM-barrels are probably both the most versatile and the most common fold for
enzymes. Thus far, members of the TIM-barrel fold have been found in all enzyme
classes except for ligases [40] [41]. They are found in all three domains of organisms
alike and catalyze many basic reactions. In fact the name TIM-barrel itself derives
from the triosephosphate isomerase, an enzyme essential for nearly every living
organism. Due to their importance in many basic reactions these enzymes are well-
studied and currently (march 2016) contribute about 2% of all the structures in the
PDB [41].
TIM-barrels belong to the α/β class of the SCOP [42] classification. They consist
of eight α/β elements with the β sheets forming the inner barrel and the α helices on
the outside. The barrel itself is held together by hydrogen bonds between backbone
atoms of the parallel β sheets. In all natural TIM-barrel enzymes, the catalytic
side is at the top of the barrel and the helix-dipoles are often used to help binding
negatively charged substrates [43].
Evolutionarily, TIM-barrels are likely to have evolved from an at least twofold
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symmetric ancestor consisting of two half barrels [44] [45] [46] [47] [48] although also
a fourfold symmetric ancestor utilizing four quarter barrels is plausible [49]. The
question whether all present TIM-barrels share a common origin or whether they
evolved independently is not yet completely answered, although much hints to the
fact that at least the majority of the known TIM-barrels indeed have a common
ancestor [50] [40] [47].
Due to the importance the TIM-barrel fold has for enzymes and to shine some
additional light onto the evolutionary aspects of this fold, the decision was made to
design a TIM-barrel completely de novo.
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4.2 Design
Design principles
There are a lot of prior attempts to design a TIM-barrel [9] [10] [11] [12] [13] [14]. In
contrast to many of these attempts, we did not try to redesign modern TIM-barrels,
but instead go for a strategy that focuses on a minimal model of an idealized TIM
barrel. As a first step to minimize our design problem we decided to create a
construct that is symmetric on both the sequence as well as the structure level. We
therefore looked into possible symmetries.
Since the TIM-barrels consist of eight α/β motifs, the idea of an eightfold sym-
metric TIM-barrel lies at hand. However, such a symmetry is structurally not fea-
sible. The reason for this lies in the interactions of the β sheets forming the inner
barrel: Since the main contributing interactions within β sheets are hydrogen bonds
between the backbone atoms, neighboring β strands have to be in the same pleat
pattern, thus show a register shift of multiples of two amino acids or have alternat-
ing pleat patterns (see Figure 4.1). The sum of all shifts of residues in neighboring
β strands is called the shear number of the barrel. In the case of the TIM-barrel
the shear number is eight, while the register shifts are usually not symmetrical over
the barrel (see Figure 4.1a for triosephosphate isomerase as an example). An eight-
fold symmetric TIM barrel is therefore not possible since the requirement to be in
the same pleat pattern would require each β strand to have a register shift of two
compared to its neighbor, leading to a shear number of sixteen. For a fourfold sym-
metrical arrangement on the other hand there are three possibilities. A register shift
of one between each β strand as shown in Figure 4.1b with an alternating pleat pat-
tern leads to half of the loops connecting α helices and β strands with helix-facing
residues which is not feasible [8]. Same goes for the possible arrangement pictured
in Figure 4.1c where each β strand ends with a helix facing amino acid. This leaves
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Figure 4.1: Possible pleat patterns of TIM barrels. (a) shows the non symmetric
solution from Triosephosphate isomerase. (b) One possible solution with alternating
pleats is not feasible due to the fact that every second lower loop has to connect a α
helix to a β strand with a helix facing terminus. (c) is even worse with every lower
loop now having to make such a connection. (d) shows the remaining solution we
focused on in this work. From [1]
.
only one fourfold symmetric possible set of register shifts and pleat patterns, pic-
tured in Figure 4.1d. Since all loops now have to connect helices with barrel-facing
residues this design should be feasible [8].
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Computational design
In order to create a starting model, the Rosetta suite was used to calculate dif-
ferent de novo designs of the quarter barrel. Each design featured β-strands with
a length of five amino acids and variable lengths of the loops and α-helices. For
each combination 2000 designs were calculated. The only combination for a quarter
barrel which resulted in a structure with a closed barrel in the simulation consisted
of 46 amino acids arranged as 5strand1 + 3loop + 13helix1 + 3loop + 5strand2 + 3loop +
11helix2 + 3loop (see Figure 4.2). Although other designs have been tested as well,
this ultimately superior combination of secondary elements followed the principles
for ideal loop lengths as described in [8]. All computations were performed by Possu
Huang in David Bakers group.
5 AA
sheet 1
13 AA
helix 1
5 AA
sheet 2
11 AA
helix 2
3 AA
3 AA
3 AA
3 AA
Figure 4.2: Schematic representation of the best solution of possible length of sec-
ondary structure elements found for a quarter barrel. AA = amino acids.
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Additional design features
Several other design features were introduced manually to increase the chance of a
correctly folded TIM-barrel as described below [1].
One of the amino acids in the loop between the different quarters was forced to
be an aspartate. This design choice was made due to the exposed amide that is a
result of the register shift between the two neighboring β-strands. The aspartate
in the loop can create a hydrogen bond to the otherwise solvent-exposed amide
and contribute to protein stability. In a similar fashion one of the amino acids in
the flanking α-helix was set to an arginine to interact with a free carbonyl in the
β/α-loop number 2 (see Figure 4.3a).
Hydrogen bonds to the backbone of the α/β-loop number 2 were also introduced
manually by the introduction of a serine into the loop and a glutamine to the adjacent
loop (see 4.3b).
Another constraint was the mandatory presence of at least one valine or leucine
in the flanking α-helices interacting with the corresponding β-strands (see Figure
4.3c, position 17, 20 and 38).
One major problem could have been the correct spacing between the α-helices.
While the diameter was mainly determined by the diameter of the inner barrel
defined by the β-sheets, defined spacing and angles between neighboring helices was
important to achieve a uniform shielding of the β-strands. This was realized by the
introduction of several tryptophans at the interface of the helices (see Figure 4.3d).
In order to maintain a high degree of symmetry even in the region of the (nec-
essary non-symmetric) termini, two cysteines were introduced in one of the last
designs into the N,- and C terminus. They were supposed to form a disulfide bond
and force these regions close together.
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Figure 4.3: Overview of the different interactions enforced in the TIM-barrel design.
(a) Hydrogen bonds introduced to saturate otherwise solvent-exposed features. (b)
Interactions introduced into one of the lower loops to restrain loop flexibility and
increase stability. (c) Different features manually introduced into the design. (d)
Tryptophans used as spacers to control the distance between different helices. (e)
The designed hydrogen bond between T26 and W42 seems to be water-mediated
according to the crystal structure obtained. From [1].
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4.3 List of constructs
During this work a variety of constructs were expressed and tested (see figure 4.3).
Listed here is an alignment of the different sequences. First constructs were the D
variants as well as TIM10. The De variants missed the Trp35 and Trp42 described
in chapter 4.2. These constructs were not properly folded. Introduction of Arg21 in
sTIM1 and all later sTIM variants increased the thermal stability of the constructs.
The sTIM variants of the last generation of designs additionally feature different
circular permutations as can be seen in the alignment.
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10. 20. 30. 40.
D10 ..MDILIVDATDK.DEARKQVEQLAREGATQIAFRSDDWRDLKEAWKKGA
D11 ..MDILIVDATDK.DEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGA
D12 ..MDILIVDATDK.DEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGA
TIM10 ..MDILIVDATDK.DEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGA
DeTim-1 MTEPIVVFKGPGGIESARKLYEQV..PPDTRIAYETDDPEEAREFLRKAP
DeTim-2 MPEPIVVFKGPGGIESARQLREKV..PPDTRIAYETDDPEEAREFLEKAP
DeTim-4 MTDPIVVFRGPGGIESARKLKEQV..PPDTRIAYETDDPEEAREFLRKAP
DeTim-5 MTDPIVVFRGPGGIESARKLKEQV..PPDTRIALETDDPETAREFLRKAP
DeTim-7 MTDPIVIFRGPGGIESARKLKEQV..PPDTRIAYETDDPEEAREFLRKAP
sTIM1 ..MDILIVDATDK.DEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGA
sTIM2 ..MDVLIVDATDK.DEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGA
sTIM4 ..MDILIVDATDK.DEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGA
sTIM5 ..MDVLIVDATDK.DEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGA
sTIM7 ....................................MDWRDLKEAWKKGA
sTIM9 .............................MQCAYRSDDWRDLKEAWKKGA
sTIM11 ..........MDK.DEAWKCVEQLRREGATQIAYRSDDWRDLKEAWKKGA
50. 60. 70. 80. 90.
D10 DI..LIVDA.TDKDEARKQVEQLAREGATQIAFRSDDWRDLKEAWKKGAD
D11 DI..LIVDA.TDKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGAD
D12 DI..LIVDA.TDKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGAD
TIM10 DI..LIVDA.TDKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGAD
DeTim-1 PNTLVIFTGPGGIESARELYKQV..PPDTRIIYETDDPEEAREFLEKAPP
DeTim-2 PNTLVIFTGPGGIESARKLMEQV..PPDVRIIYETDDPEEAREFLKKAPP
DeTim-4 PDTLVIFRGPGGIESARELKKQV..PPDTRIIYETDDPEEAREFLEKAPP
DeTim-5 PDTLVIFRGPGGIESARELKKQV..PPDTRIILETDDPETAREFLEKAPP
DeTim-7 PDTLVIFRGPGGIESARELKKQV..PPDTRIFYETDDPEEAREFLEKAPP
sTIM1 DI..LIVDA.TDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAD
sTIM2 DI..LIVDA.TDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAD
sTIM4 DI..LIVNA.TDKDEAWKQVEQLRREGATQIAYTSDDWRDLKEAWKKGAD
sTIM5 DI..LIVNA.TDKDEAWKQVEQLRREGATQIAYTSDDWRDLKEAWKKGAD
sTIM7 DI..LIVDA.TDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAD
sTIM9 DI..LIVDA.TDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAD
sTIM11 DI..LIVDA.TDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAD
100. 110. 120. 130. 140.
D10 I...LIVDATDKDEARKQVEQLAREGATQIAFRSDDWRDLKEAWKKGADI
D11 I...LIVDATDKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGADI
D12 I...LIVDATDKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGADI
TIM10 I...LIVDATDKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGADI
DeTim-1 NTLVLFTGPGGIESARRLYEQV..PPDTRIAYETDDPEEAREFLRKAPPN
DeTim-2 NTLVLFRGPGGIESARELVERV..PPDTRIAYETDDPEEAREFLEKAPPN
DeTim-4 DTLVLFRGPGGIESARRLKEQV..PPDTRIAYETDDPEEAREFLRKAPPD
DeTim-5 DTLVLFRGPGGIESARRLKEQV..PPDTRIALETDDPETAREFLRKAPPD
DeTim-7 DTLVLFRGPGGIESARRLKEQV..PPDTRIAYETDDPEEAREFLRKAPPD
sTIM1 I...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
sTIM2 V...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
sTIM4 I...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
sTIM5 V...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
sTIM7 I...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
sTIM9 I...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
sTIM11 I...LIVDATDKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADI
70 CHAPTER 4. DE-NOVO DESIGN OF A TIM-BARREL
150. 160. 170. 180.
D10 LI..VDAT.DKDEARKQVEQLAREGATQIAFRSDDWRDLKEAWKKGALE.
D11 LI..VDAT.DKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGALE.
D12 LI..VDAT.DKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGALE.
TIM10 LI..VDAT.DKDEAWKQVEQLAREGATQIAYRSDDWRDLKEAWKKGA...
DeTim-1 TLVIFRGPGGIESARKL..KEKVPPDTRIAYETDDPEEAREFLEKGGGSG
DeTim-2 TVVIFKGPGGIESAREL..QERVPPDTRIAYETDDPEEAREFLEKGGGSG
DeTim-4 TLVIFRGPGGIESARKL..KEKVPPDTRIAYETDDPEEAREFLEKGGGSG
DeTim-5 TLVIFRGPGGIESARKL..KEKVPPDTRIALETDDPETAREFLEKGGGSG
DeTim-7 TVVVFRGPGGIESARKL..KEKVPPDTRIAYETDDPEEAREFLEKGGGSG
sTIM1 LI..VDAT.DKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAGGS
sTIM2 LI..VDAT.DKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGAGGS
sTIM4 LI..VNAT.DKDEAWKQVEQLRREGATQIAYTSDDWRDLKEAWKKGAGGS
sTIM5 LI..VNAT.DKDEAWKQVEQLRREGATQIAYTSDDWRDLKEAWKKGAGGS
sTIM7 LI..VDAT.DKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADIL
sTIM9 LI..VDAT.DKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADIL
sTIM11 LI..VDAT.DKDEAWKQVEQLRREGATQIAYRSDDWRDLKEAWKKGADIL
D10 .................................
D11 .................................
D12 .................................
TIM10 .................................
DeTim-1 GSWLE............................
DeTim-2 GSWLE............................
DeTim-4 GSWLE............................
DeTim-5 GSWLE............................
DeTim-7 GSWLE............................
sTIM1 GGSLE............................
sTIM2 GGSLE............................
sTIM4 GGSLE............................
sTIM5 GGSLE............................
sTIM7 IVDATDKDEAWKQVEQLRREGATQIAYRSDGLE
sTIM9 IVDATDKDEAWKQVEQCRREGATGLE.......
sTIM11 ICDATGLE.........................
Figure 4.4: Alignment of the different variants designed and experimentally tested by
me. The alignment was done with Clustal Omega [51] [52] [53], the representation
was done using the TEXshade-package. the colors represent different amounts of
sequence conservation.
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4.4 Characterisation
Expression and purification
All genes of the different variants were send to us in either pet21 or pet29 plasmids
by Possu Huang from David Bakers lab. The plasmids were used for transforma-
tions into E. coli BL21 cells utilizing the heat shock protocol (see chapter 3.1) and
expression took place at 30◦C over night according to 3.2. Interestingly the proteins
only expressed in TB medium, neither LB nor self inducing media based on ZY
medium led to significant amounts of protein.
Purification was done with a Ni Sepharose column (see Figure 4.5), followed by
size exclusion chromatography using a preparative S75 column (see Figure 4.6).The
fractions containing the construct were pooled and concentrated. For most con-
structs between 1 mg/l and 5 mg/l were purified.
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Figure 4.5: Affinity column run of sTIM11 with a 1ml Ni Sepharose
column on the AEkta purifier. Elution starts at roughly 150mM Imi-
dazole. Red lines at the x-axis signify fractionation borders from the
sample collector. The blue box indicates the fractions ultimately used
for further purification. The green line indicates the calculated gradient.
Buffer A: 150mM NaCl, 50mM potassium phosphate pH 8.0, 10mM Imidazole.
Buffer B: 150mM NaCl, 50mM potassium phosphate pH 8.0, 1M Imidazole.
4.4. CHARACTERISATION 73
0 20 40 60 80 100 120 140 160 180 200 220
0
20
40
60
80
100
120
140
160
180
200
220
ml
m
A
u
A280nm
Figure 4.6: Size exclusion chromatography of sTIM11 run with a Superdex S75
column on the AEkta prime for further purification and to remove higher order
oligomers. Red lines at the x-axis signify fractionation borders from the sample
collector. The blue box indicates the fractions ultimately used further. The running
buffer was 150mM NaCl, 50mM potassium phosphate pH 8.0.
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Biophysical characterisation
As a measure of secondary structure content, CD spectra were recorded for all
purified constructs. If secondary structure was present, tryptophan fluorescence
was used to get an estimate of tertiary structure formation. In ambigous cases 2D
NMR spectra were recorded.
If both CD and Trp fluorescence were satisfactory, melting curves were recorded
measuring changes in CD signal upon heating (see figure 4.8). The resulting curves
were used to estimate the melting point of the construct.
The first designs had already flaws at the level of secondary structure as shown
by CD (See Figure 4.7). Later designs showed an increasing content of secondary
structure.
Figure 4.7: Overview of first selection based on CD spectra and examples at different
stages of the design process. From [1].
4.4. CHARACTERISATION 75
20 25 30 35 40 45 50 55 60 65 70 75 80 85 90
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1.1
T in ◦ C
fr
ac
ti
on
u
n
fo
ld
ed
TIM10
D10
D11
sTIM7
Figure 4.8: Melting curves of different constructs at a concentration of 0.3 mg/ml in
150mM NaCl, 50mM potassium phosphate buffer pH 8.0. The fraction of unfolded
protein was determined by the amount of CD signal at 222nm.
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Since secondary structure content does not necessarily imply the presence of ter-
tiary structure additional experiments had to be done to ensure that the constructs
were indeed folded.
Tryptophan fluorescence is usually used to determine structural integrity. How-
ever, many of the constructs incorporate solvent-exposed tryptophans and therefore
differences between folded and unfolded states might be small. Without a spectrum
of a very similar and reliably folded construct as a comparison it would be difficult
to determine whether the fluorescence spectrum belongs to a folded or unfolded pro-
tein. I therefore decided in critical cases to use one dimensional NMR to determine
the presence of a defined tertiary structure.
In the case of a stable protein with a defined fold, a one dimensional NMR
spectrum will show clear methyl peaks under 0 ppm. If - as in our constructs -
tryptophans are present, one would also expect visible peaks around 9 ppm. Figure
4.9 shows the comparison of one of the constructs, D10, with a protein which is
known to be folded (hRhoA from Silke Wiesner). Both features, the methyl peaks
as well as the peaks resembling tryptophans, are present in the hRhoA spectrum
and missing in the spectrum of the D10 variant. This leads to the conclusion that
D10 is not present in a properly folded state.
Similar 1D NMR spectra were recorded for a variety of the later variants and
even in the third generation of constructs none of the candidates showed any sign
of a stable secondary structure (see Figure 4.10).
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Figure 4.9: 1D-NMR spectrum of the TIM D10 variant (blue) in comparison to
the spectrum of a folded protein (hRhoA, purified and recorded by Silke Wiesner).
Both the methyl peaks under 0 ppm (b) and the tryptophan peaks around 9 ppm (a)
are missing in the D10 spectrum. D10 spectrum recorded in 150mM NaCl, 50mM
potassium phosphate buffer pH 8.0
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Figure 4.10: 1D-NMR spectra of different constructs. The missing methyl peaks
that would be expected around 0 ppm and the also expected peaks around 8-10
ppm resulting from the tryptophans present in all of the constructs hint to the fact
that the proteins are probably not present in a folded state.
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In contrast to most earlier designs, sTIM11 showed a strong CD signal resembling
a mixed α-helix and β-sheet content (see Figure 4.11). A melting curve was recorded
from sTIM11 and changes in signal were recorded at a wavelength of 222 nm. Un-
folding was not completely cooperative and minor changes were already recorded
at lower temperature, indicating that probably flexibility between the α helices in-
creases already long before the protein itself unfolds. Thermal denaturation was fully
reversible and, the CD signal was fully restored upon cooling to 30◦C. Subsequent
melting showed identical behavior (see Figure 4.12).
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Figure 4.11: CD spectrum of sTIM11 at a concentration of 0.3mg/l in 150mM NaCl,
50mM potassium phosphate buffer pH 8.0. The second sample was heated to 95◦C
for a melting curve and then cooled down again.
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Figure 4.12: sTIM11 unfolds reversibly as shown by repetitive melting. Shown is
the amount of unfolded protein recorded using the change in CD signal at 222nm
upon heating with a rate of 1◦ C/min. The protein concentration was 0.3mg/ml in
150mM NaCl, 50mM potassium phosphate buffer pH 8.0.
Since the design features a disulfide bond between the N and the C termini, we
were interested in the contribution of the proposed disulfide bond to the stability of
the construct. In order to measure this contribution melting curves with continuous
measurements of the CD spectrum at 222nm were recorded in the presence of an
excess of DTNB. DTNB binds to free cysteines, thus making it impossible to form
disulfide bonds. Both the construct with as well as without DTNB present were
heated to 95◦C, cooled down to room temperature and heated again. No differences
were detected between the two setups, already hinting at the fact that the disulfide
bonds did not form (see Figure 4.12).
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Figure 4.13: The cysteines introduced to form a disulfide bond between the N and
the C termini have no effect on stability. This is shown by repetitive melting of
sTIM11 in the presence and absence of an excess of DTNB, which seems to have no
effect on the thermal stability. Since DTNB binds to free cysteines, thus inhibiting
the formation of disulfide bonds, a contribution of the expected disulfide bond to
stability should lead to a higher melting temperature in the absence of DTNB. The
melting curves were recorded at a concentration of 0.3 mg/ml in 150mM NaCl,
50mM potassium phosphate buffer pH 8.0 at a heating rate of 1◦C/min.
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In order to compare the stability of the construct with natural TIM-barrels, I
decided to determine the change in Gibbs energy upon unfolding utilizing a chem-
ical unfolding study. I used increasing concentrations of guanidinium chloride as a
chaotropic agent to destabilize the protein. For each concentration of guanidinium
hydrochloride, a tryptophan fluorescence spectrum was recorded using an excitation
wavelength of 280nm. Comparing the spectra of folded and unfolded construct, the
highest difference was observed at a emission wavelength of 377nm while nearly no
difference was visible at 344nm (see Figure 4.14). The emission at 377nm was there-
fore used to determine the fraction of unfolded protein, while the emission at 344nm
was used to normalize for errors resulting from slight concentration differences of
the different samples. The fraction of the emission signal at these two wavelengths
led to a typical unfolding curve. Compared to unfolding of the secondary structure
content measured by CD signal at 222nm, the unfolding begins at a little higher
concentration of guanidinium hydrochloride but corresponds to the CD signal at
higher concentrations (see Figure 4.15).
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Figure 4.14: Tryptophan fluorescence of folded and unfolded sTIM11 in buffer and
buffer + 5M guanidine HCL. Excitation wavelength was 280nm. Also shown are the
wavelength of the largest (377 nm) and smallest (344 nm) change as determined by
maximum and minimum of the mean deviation from the median of all concentrations
measured.
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Figure 4.15: Chemical denaturation of sTIM11. The unfolding curves measured
with CD and with Trp fluorescence are quite similar, indicating a simultaneous loss
of secondary and tertiary structure. The only exception is the early decrease in CD
signal at low concentrations of guanidinium hydrochloride. This could be due to
unfolding of the probably more flexible first α-helix.
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Figure 4.16: Determination of the change in Gibbs energy upon unfolding. ∆G is
estimated to be 4.117 ± 0.088 kcal/mol (α=0.05) with no guanidinium hydrochloride
present. Basis of the fit are the changes in Trp fluorescence in the concentration
range where the change of signal was most rapid.
The unfolding data was used to calculate the change in Gibbs energy as described
in Chapter 3.3. Based on the observed unfolding curve, the estimated change in
Gibbs energy upon unfolding in a solution free of guanidinium hydrochloride was
estimated to be 4.117 ± 0.088 kcal/M. This is less than the majority of the inten-
sively studied (thermostable) natural TIM-barrels. For a designed protein however
this represents a very good value.
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X-ray structure determination
Crystallization screens were setup for the constructs TIM10, sTIM7, sTIM9 and
sTIM11. These were quite willing to crystallize, however the crystals either did not
show any visible diffraction or the diffraction observed was so low that no structure
could be solved (worse than 5 A˚). For sTIM11, however, two datasets could be
recorded with the better one diffracting up to a resolution of 2 A˚.
The diffraction data was processed with XDS and the space group was deter-
mined to be P 41 21 2 (92). Notably the Wilson B factor was quite high for a
structure with this resolution (see table 4.1). This is already a hint that there is
probably either a high flexibility within the protein or errors in the crystal lattice.
In a fourfold symmetric barrel such an error could for example be an alternating
orientation of the termini between different copies.
Molecular replacement was done using the backbone atoms (C, CA, O and N in
the pdb nomenclature) of a Rosetta model of sTIM11.
4.4. CHARACTERISATION 87
recording parameters
Wavelength (A˚) 1
Resolution range (A˚) 46.79- 1.992 (2.064- 1.992)
Space group P 41 21 2
Unit cell
a, b, c (A˚) 50.08, 50.08, 131.28
α, β, γ (◦) 90, 90, 90
Total reflections 69721 (5756)
Unique reflections 11894 (1083)
Multiplicity 5.9 (5.3)
Completeness (%) 98.26 (93.20)
Mean I/sigma(I) 15.24 (1.79)
Wilson B-factor 41.84
R-merge 0.05804 (0.6607)
R-meas 0.06359
CC1/2 0.999 (0.762)
CC∗ 1 (0.93)
Reflections used for R-free 595 / 5%
R-work 0.2237 (0.2882)
R-free 0.2607 (0.2989)
Number of non-hydrogen atoms 1481
macromolecules 1461
water 20
Protein residues 180
RMS(bonds) 0.013
RMS(angles) 1.21
Ramachandran favored (%) 96
Ramachandran outliers (%) 0
Clashscore 3.17
Average B-factor 61.90
Table 4.1: Parameters of the crystal structure 5BVL of sTIM11
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4.5 Evaluation of sTIM11
Evaluation of the crystal structure
The crystal structure obtained shows an overwhelming similarity to the designed
model. The structure superimposed to the design with a Cα-RMSD of 1.28A˚and
even most of the sidechains were in conformations similar or identical to the calcu-
lated model. Many of the features designed manually could be found in at least some
of the quarter barrels (see figure 4.3). There were however also some differences be-
tween the model and the actual crystal structure. Most notably, the disulfide bond
intended to connect the N- and C-termini did not form (see figure 4.17). This was
probably due to the usage of non-optimal rotamers for the cysteines in the design.
Tryptophan 42 intended to control the distance between the helices differed quite a
bit from the design, however the other tryptophans in the quarter barrel introduced
for the same purpose perfectly matched their predicted position (see figure 4.3d).
This deviation might be due to the fact that the hydrogen bond designed between
threonine 26 and tryptophan 42 is not formed directly but mediated by a water
molecule (see figure 4.3e).
Relations to other TIM barrels
As interesting as a de novo design might be by itself, it is equally fascinating to
compare the designed construct on a sequence level to natural proteins utilizing the
same fold. This is important due to two reasons. On the one hand I had to make
sure that the design was not biased too much by existing proteins. This is especially
true for algorithms such as Rosetta utilizing natural fragments in the design process.
On the other hand it can also give us an insight into the sequence space itself and
how much of it is actually covered by known natural proteins.
In contrast to structure-based search procedures, detecting similarities based on
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Figure 4.17: Closeup on the designed disulfide bridge intended to connect the N and
the C termini. The disulfide bridge can not form with the geometry observed.
the sequences was more difficult. Standard psi-blast searches using three iterations
did not detect any similarity to other TIM-barrels. More sensitive profile-based
searches with HHsearch [54] however were able to find some commonalities with
low probabilities (the best p-value to another member of the TIM-barrel family was
8.4E-06 with a quarter and 1.8E-08 with the full-length protein, both against the
SCOPe95 2.06, no secondary structure scoring, 3 iterations). I therefore created a
database with the sequences of all TIM-barrels in the SCOPe as well as sTIM11.
Similarities between all pairs of sequences were calculated and used for clustering.
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Figure 4.18: Cluster of representatives of all different TIM-barrel families present in
the SCOPe. The sequence similarity scores were calculated with HHblits. sTIM11
is represented as a red star. Clustering was done with CLANS [31]
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The natural TIM-barrels are highly connected, not only within the families but
also between different families and even superfamilies (see Figure 4.18). In fact
borders between different superfamilies are often not clearly defined and the existing
SCOP classification is difficult to justify just based on the similarity scores observed.
This is especially true for many of the superfamilies of c.1.1-c.1.10.
If we now compare these highly interconnected sequences to the sequence of
sTIM11, the latter shows only a few, quite improbable similarities to natural TIM
barrels (compare Figure 4.18). Although there are sequences that are even more
isolated (the only member of superfamily 25, Monomethylamine methyltransferase
from Methanosarcina barkeri does not show a single significant sequence similarity),
sTIM11 seems not only to have a quite unique sequence but also a much lower
similarity to other TIM-barrels than most other members of this superfamily would
have.
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4.6 Discussion
The design goal, a de novo TIM-barrel, was met as shown by the crystal struc-
ture. Moreover, the resulting protein is remarkably stable for a designed protein
and shows several beneficial attributes such as the capability to refold completely.
Independent of the fact that this protein did not evolve naturally it is quite interest-
ing. It features an extremely minimalistic structure which probably puts it amongst
the smallest possible TIM-barrels. It also incorporates an almost perfect fourfold
symmetry, giving rise to the possibility that the ancestral TIM-barrels have evolved
from quarter barrels. As expected for a true de novo design, the sequence used
shows no close relations to any natural TIM-barrel, in fact only the most sophisti-
cated profile-based search algorithms are able to find any similarities with quite low
significance.
This design expands our landscape of man-made proteins on quite some frontiers.
It is so far the biggest de novo designed globular protein, its stability without any
experimental optimization is remarkable and it is the first successful design of the
most important fold for enzymes. Its stability, symmetry on both the sequence as
well as the geometric side and the fact that the protein was thus far only optimized
for its geometry and does not bare any evolutionary deadweight should help develop
it into enzymes with very different demands.
The design was published in Nature chemical biology [1] and is already subject to
further research on both its structural as well as functional potential. Gregor Wiese
from the University of Tu¨bingen started working on designs based on sTIM11 and
will continue to do so in his Master Thesis.
Chapter 5
Rational design of a new protease
5.1 Overview
There are two main motivations for the design of new enzymes. On the one hand
there are a number of beneficial reactions that no natural enzymes are known to
catalyze. To be able to design enzymes for these cases would be beneficial for a
variety of applications. On the other hand enzyme design can also be seen as the
ultimate proof of our understanding of a specific reaction mechanism.
Independent of the motivation for the design of new enzymes, at the current
state the successful designs catalyze energetically easy reactions. Many interesting
reactions for both application as well as investigation of the mechanism however are
quite challenging, often needing several catalytic steps to complete.
In order to extend the field of enzyme design towards more difficult reactions,
this part deals with the design of a protease. The ability to design new proteases
would on the one hand open a variety of applications. The catalytic mechanism I
intend to use, the catalytic serine triad, is on the other hand one of the best-studied
enzymatic mechanisms and being able to design a functional triad would ensure us
that our understanding of its mechanism is quite thorough.
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The design strategy used is based on the insertion of a catalytic serine triad
into an existing host scaffold. This strategy has been successfully used for enzyme
designs before [15] [17] [20] [19], however it imposes some additional problems for
the insertion of the catalytic triad. Since the geometric definition of the catalytic
triad only allows for a very small conformational space, the probability to find an
insertion site in a given number of possible host scaffolds is much lower than for
the more loosely defined geometries of most prior designs. It is therefore necessary
to drastically increase the number of screened host scaffolds and while most prior
studies used Rosetta Match to screen databases of around 200 structures [21] this
work aimed for a system able to screen the whole protein database.
In order to screen large databases effectively, certain simplifications have to be
performed in the early stage of the design. Since energy calculations are very resource
intensive and also of limited use before the actual pocket design takes place, only
geometric considerations are used to initially find possible insertion sites. After
the amount of insertion sites is reduced to a manageable number, more complex
calculations can be made. More specifically I used consecutive runs of Rosetta relax
and Roseta enzyme design to figure out which insertion sites can be made into a
functional enzyme (see later chapters for a more detailed description). These reduce
the amount of possible designs further until in the end only a small number of designs
has to be evaluated experimentally. Figure 5.1 gives an overview of the amount of
data dealt with at different stages of the design procedure and the tools involved.
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Figure 5.1: Overview of the design strategy and usage of the different tools. In blue
are tools making only use of the geometry without considering energy. These parts
are based on ScaffoldSelection and the result of ScaffoldSelection runs.
Green are calculations that use energy terms. These are based on Rosetta relax (for
a first overview of the energetic feasibility of an insertion site) as well as Rosetta
Enzyme design (for optimization of the binding pocket). Red is actual experimental
work.
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5.2 ScaffoldSelection
In order to screen large quantities of possible host scaffolds a program called Scaf-
foldSelection was developed in our group several years ago by Christoph Malisi
in collaboration with Oliver Kohlbacher [24] [55]. ScaffoldSelection uses a
geometric definition of a desired motif and searches a database of structures for pos-
sible insertion sites. Such a motif usually consists of the amino acids that have to be
placed, a placeholder for a ligand or substrate that has to be bound in a geometry
relative to the introduced sidechains and additional conditions on the insertion sites
such as the presence of specific atoms at certain positions. The set of all of these
elements and the desired geometry they should appear in is called a theozyme [56].
ScaffoldSelection creates an inverse rotamer tree of said amino acids that is
superimposed on their functional atoms. Every final node of the rotamer tree repre-
sents a possible insertion site into the protein backbone. This method is similar to
other programs developed for the same task (like Rosetta Match), however is much
faster, allowing the screening of the whole pdb within hours on a small cluster.
In order to reduce the computational effort, ScaffoldSelection first searches
for cavities on the protein surface that might support a binding site. ScaffoldS-
election then tries to fit the members of the inverse rotamer trees the representa-
tion of the ligand or substrate into these pockets. Clashes of the protein backbone
with both the placed amino acids as well as the ligand are evaluated. In contrast
clashes of the placed motif with sidechains of the host scaffold are neglected since
ScaffoldSelection assumes that sequence optimization is taken care of in later
optimization steps. If a requirement for the presence of certain atoms at specific
positions was set, ScaffoldSelection will filter all insertion sites that do not
meet these criteria in an additional step.
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Next to the position of the catalytic triad’s active atoms, the existence of a
nitrogen atom at a position where it could function as a oxyanion hole was also
set as a requirement. Since the position of the oxyanion hole can be quite variable
in natural proteases, I started several runs of ScaffoldSelection in parallel,
each with a different required oxyanion hole position. The results of these different
ScaffoldSelection runs were then united and evaluated together.
The evaluation itself was based on four different criteria:
• Backbone clash score, which evaluates clashes of the inserted amino acids
with the backbone of the host scaffold
• Catalytic geometry penalty, which evaluates differences between the in-
serted amino acids and the template
• Rotamer frequency score, which evaluates how common the rotamers of
the inserted amino acids are
• Substrate clash score, which evaluates clashes of the substrate with the
backbone of the host scaffold
One of the problems when working with ScaffoldSelection is that a single
insertion site is evaluated independently for all of these criteria. If it fails to meet
the requirements for one of these scores, the site will still be present in all of the
other lists. Therefore, if ScaffoldSelection is allowed to select for the highest
scoring insertion sites, this will typically lead to a very low amount of complete hits
where all scores are present. This is especially problematic for the Backbone clash
score, which is in most cases zero. If ScaffoldSelection filters a certain amount
of insertion sites as implemented, this leads to a random selection of insertion sites
that score good in said score.
This was the reason I disabled initial sorting by ScaffoldSelection and in-
stead used all found insertion sites for further analysis. For this purpose scripts were
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written that collect and allocate the scores for all insertion sites. Based on these
collated quadruples of scores selections of credible positions were made.
The definition of a credible position according to the ScaffoldSelection
scores is a position that scores similar to a natural protease. Since Scaffold-
Selection gives not one score but four, I started by optimizing possible sets of
weights and filters for these scores to identify the best scaffolds for the intended
design.
The goal of these optimizations was to find a set of filters (thresholds for each
score type that cannot be undercut) and weights (a linear weight multiplied with
the score in order to give it more or less relevance) that perform well in the sense
that natural proteases score very good. I therefore performed ScaffoldSelection
searches on a set of pdb structures that not only contained possible host scaffolds
but also structures that reportedly already contain the catalytic triad as a test set.
Insertion sites in the test set were identified by my scripts and I evaluated how they
scored under different evaluation criteria.
The goal was to find a set of parameters that enriches the natural proteases in
the top scoring insertion sites. Due to the different spread of scores it was however
not possible to find weights that would lead to the desired result. I therefore derived
new scores by calculating the rank of each score compared to all other scores. Filters
were still used on the basis of the raw scores, but weights were applied to the ranks
instead. Especially strict filters were applied to the Backbone clash score. This
was due to the fact that most insertion sites had a Backbone clash score of zero
resulting in a rank of one. These ranks were therefore quite meaningless and hence
were not used for further evaluation. Using different sets of weights or in some cases
only the Catalytic geometry penalty ranks lead to the desired enrichment of natural
proteases in the top percentiles (see Figure 5.2).
Insertion sites that scored in the area dominated by positions found in natu-
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Figure 5.2: Graphic representation of the best 4500 insertion sites found in one
ScaffoldSelection run. The red bars indicate the amount of positions found in
the test cases consisting of structures of roughly 2500 serine proteases. The blue
bars indicate positions found in the 43.000 PDB structures searched for potential
insertion sites.
ral proteases were extracted. These have a geometric feasibility similar to already
existing triads and were therefore classified as ”geometrically credible”. However,
further steps were needed to ensure that they were also energetically probable.
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5.3 Preliminary energetic evaluation
Before starting a complete pocket optimization with the introduction of mutations
in the proposed binding pocket, the general energetic feasibility of the insertion was
evaluated utilizing the Rosetta relax application.
For this purpose, each insertion site was placed with the motif construction tool
from ScaffoldSelection and prepared for Rosetta runs. Around 100 uncon-
strained relaxes were calculated for each model. The resulting relaxed files were
then loaded and differences to the theozyme were calculated. In order to reduce
these differences to a single number, I calculated the spacial deviation of the dis-
tances between the atom OG from serine and the atom NE2 from histidine (d1) and
the atom ND1 from histidine and the atom CG from aspartate (d2) and compared
them to the theozyme distances (D1 and D2 respectively):
d1 := ||OGSer −NE2His||2
d2 := ||ND1His −CGAsp||2
K =
√
(d1−D1)2 + (d2−D2)2
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These plots were used to quickly compare the integrity of the catalytic triad after
the relaxes. If large deviations were observed in the majority of cases the insertion
site was rejected (see figure 5.3).
(a) 1CHG (b) 2D52 (c) 1W2C
Figure 5.3: Evaluation of the result of a Rosetta relax experiment. Plotted is
the deviation of the distances of the members of the catalytic triad relative to each
other from the distances in the theozyme. (a) shows chymotrypsin as a positive
control. The catalytic triad maintains its geometry in most relaxes. (b) shows an
example of a good candidate. Again, the designed triad maintains its geometry. (c)
is an example for a candidate failing this test. In many relaxes the catalytic triad
deviates from the design goal as indicated by the large amount of structures with a
high distance difference.
The remaining insertion sites (around 20) were evaluated manually. Several
candidates were rejected due to criteria such as insertion of the triad into a hinge
region or geometries that were only observed in proteins with bound ligands. Those
that seemed viable were optimized using the program Rosetta Enzyme design.
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5.4 Pocket optimization
In order to not only optimize for the formation of the catalytic triad but also for
substrate binding, I included ApNA as the desired substrate into the calculations. I
decided to optimize for the state of the first tetrahedral intermediate. The formation
of this state is arguably the most difficult part of the reaction although also later
stages have been reported to be troublesome to design [22]. This, however, requires
a model of ApNA in the first tetrahedral intermediate state.
First, I tried to define a noncanonical amino acid resembling serine and the bound
ApNA, intending to exchange the active serine with this amino acid and optimizing
the sequence for this construct. Unfortunately, Rosetta 3.3 builds the rotamers
based on rotamer trees and seems to be incapable of handling a branching tree,
which is required to create all possible rotamers of the serine-ApNA construct (see
Figure 5.4). Therefore, I decided to include a library of all possible rotamers created
Figure 5.4: Model of Serine with ApNA covalently bound. Pink bonds indicate the
edges of the rotamer tree. Note the branching of the rotamer tree at the central
carbon atom.
with FROG2 [30] of ApNA and constrain it to the serine to a position mimicking the
tetrahedral intermediate. This was either achieved by the introduction of a virtual
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atom (which is an atom with a radius of zero and no van-der Waals interactions with
other atoms) bound to the carbon that would bind to serine. This virtual atom was
then subsequently forced to superimpose with the serine oxygen during the design.
Alternatively, the distances and angles of the cleavage site were constrained relative
to the oxygen of serine. Additional constraints were set up between the functional
atoms of serine and histidine on the one hand and histidine and aspartate on the
other hand to ensure that the catalytic triad would stay intact.
Depending on the host scaffold, either all positions except for the triad were
allowed to mutate, only positions in the supposed binding pocket, or a combination
of both where first all positions were allowed to mutate and the results were used
to identify important positions, which were in a second run exclusively allowed to
change. Up to several thousand runs were started with different parameters. One
of the initial problems was that Rosetta introduced many mutations, most of them
at positions distant to the insertion site. In order to control this behavior the fa-
vornat option of Rosetta was used. This option introduces a specific penalty for
each introduced mutation and thereby forces Rosetta to reject introduced muta-
tions that result in an energy improvement worse than the specified threshold. The
exact penalty required to keep the amount of mutations in a reasonable range differs
from scaffold to scaffold and was determined individually for each host structure.
By combining design runs with different favornat penalties I was able to produce
sets of designs with a wide range of numbers of mutations (see figure 5.5). These
were combined and evaluated together for each scaffold.
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Figure 5.5: Collection of different design runs of one of the proposed insertion sites
(3N8M, insertion into residue 51 (Serine), residue 17 (histidine) and residue 13
(aspartate)). Each cross represents one design with a specific set of mutations.
As expected a larger number of mutations allows Rosetta to find more optimal
solutions resulting in a lower total energy. In this specific case a low amount of
mutations (around six) is enough to reach an energy plateau of ≈ -165 REU (Rosetta
Energy Units) that is maintained even if more mutations are allowed.
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All designs for a certain insertion site were combined and used to derive parame-
ters such as the frequency of certain mutations or the probability to be cointroduced
with specific other mutations. Residues that were mutated in the majority of cases
were identified as especially problematic and paid special attention to when consid-
ering final designs (see Figure 5.6 for an example).
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Figure 5.6: Frequencies of mutations at position 50 in one of the insertion sites
(3N8M, site 51-17-13). In nearly all designs the original aspartate was mutated.
This is a strong hint that the aspartate is quite problematic once the triad is inserted
and should be taken care of.
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After this pre-analysis, single designs that combine both low energy and a low
number of mutations were inspected manually and patterns derived from the prior
statistics were looked for. Since the Rosetta design runs used constraints to enforce
the formation of the catalytic triad, additional unconstrained relaxes were done with
promising candidates. These relaxes did, however, not include the substrate model
since the clashes between the serine and the substrates force the ApNA out of the
binding pocket. The best scoring relaxes were evaluated manually and if the triads
formed as expected the designs were chosen for experimental evaluation (see figure
5.7). In total several final designs were made based on five insertion sites found by
ScaffoldSelection and an additional insertion site manually derived from one
of these. These 6 insertion sites were placed in 4 different scaffolds.
(a) Theozyme triad positioned in a possible
host scaffold
(b) relax of the same scaffold after the triad
was inserted and the sequence optimized
Figure 5.7: Comparison of a part of a host scaffold (a) in blue and the placed triad
after optimization of the binding pocket and relaxation (b).
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5.5 Experimental construction and validation of
designs
The initial set of designs was later extended by a manually designed insertion site
based on an insertion found by ScaffoldSelection (see chapter 5.11 for more
information). The triads were inserted into a variety of proteins from a diverse set of
organisms (see table 5.1) The different variants were created by either cloning from
Host Scaffold Organism Insertion site Results
3N8M / Grb2 SH2 Domain H. sapiens S53, H13, D17 Several constructs, had to be refolded, no detectable activity
3N8M / Grb2 SH2 Domain H. sapiens S51, H17, D13 Manually designed insertion site, three constructs, not yet tested
2D52 / chromone synthase A. arborescens S83, H85, D90 Eight constructs, instable, low expression, no activity
2D52 / chromone synthase A. arborescens S130, H132, D136 One construct, no expression
1W54 / Porphobilinogen synthase P. aeruginosa S125, H84, D322 No activity, low expression, Rosetta not improving energy
2CFM / DNA ligase P. furiosus S268, H533, D530 Several constructs, activity in one variant
Table 5.1: Overview over the different insertion sites and their corresponding host
scaffolds. In all cases wild type proteins were cloned and expressed as well.
genomic DNA or ordering the gene with a codon-optimized sequence from Thermo
Fisher GeneArtTM translating into the desired protein directly. Mutations were
introduced by PCR using according primers and all constructs were introduced into
the vector pet21a. The DNA insertions were sequenced and the expression strains
(BL21 or BLR) were transformed with the plasmids. Expression was optimized and
depending on the variant different expression temperatures, length and media were
used. Expression was induced either by addition of IPTG or automatically when
using self-inducing media.
5.6 Purification and enzymatic assays
After expression the cells were pelleted, washed and cracked open by sonication.
After centrifugation, the desired protein in the supernatant was purified utilizing
first a NiNTA column followed by analytical gel filtration. Fractions containing the
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protein were pooled and concentrated. In the case of 2cfm variants, 4h of expression
at 37◦C, purification and measurements had to be done on the same day due to
the instability of the constructs. The resulting purified proteins were characterized
biophysically and used for enzymatic activity measurements.
5.7 Activity in a 2cfm variant
Activity measurements
Catalytic activity with ApNA as a substrate was measured with a variety of 2cfm
constructs repeatedly. An activity over background was only detected with ApNA
as the substrate and 2cfm v12, which had only one additional mutation next to the
triad, a phenylalanine introduced at position 253 (see figure 5.8). All other variants
showed no activity over background.
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Figure 5.8: An enzymatic assay of 2cfm wild type with ApNA as a substrate shows
only background activity. With the variant v12 the catalytic turnover is clearly
improved. Measurements were taken with 100µM ApNA in 150mM NaCl, 50mM
potassium phosphate buffer pH 8.0.
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In order to test whether the catalytic triad is responsible for the observed activity,
each of the three amino acids from the catalytic triad was exchanged back to the wild
type and an activity measurement was performed with each construct. Each of the
knockouts led to a complete loss of activity (see Figure 5.9), leading to the conclusion
that most likely all residues in triad are indeed responsible for the observed turnover.
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Figure 5.9: Compared to the active variant, mutations of each of the amino acids of
the catalytic triad lead to a loss of function. This implies that all amino acids are
important for catalysis. Measurements were taken with 100µM ApNA in 150mM
NaCl, 50mM potassium phosphate buffer pH 8.0.
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In another assay both PMSF and AEBSF as inhibitors of the catalytic triad were
tested for their ability to decrease the activity of the construct. In order to do so,
fresh protein was incubated with either PMSF or AEBSF for one hour. After that,
an activity assay with ApNA as a substrate was performed. While PMSF seems to
have no effect, AEBSF is able to decrease the observed activity considerably (see
figure 5.10).
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Figure 5.10: Both PMSF and AEBSF were tested for their capability to inhibit the
catalytic triad. While PMSF shows no effect, AEBSF leads to a loss of function
similar to background. Measurements were taken with 100µM ApNA in 150mM
NaCl, 50mM potassium phosphate buffer pH 8.0.
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I measured activity of 2cfm v12 at different concentrations of ApNA and derived
a classical Michaelis-Menten kinetic (see figure 5.11). The KM was estimated to be
224 µM and the catalytic efficiency was calculated to be 0.0278 molecules per min.
This leads to
kcat
KM
= 124
1
M×min
The rate acceleration was rather low and calculated to be
kcat
kuncat
= 1006
where kuncat was calculated from the hydrolysis of free ApNA observed in the
control experiments.
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Figure 5.11: Enzymatic activity of 2cfm v12 at different concentrations of ApNA.
The KM is estimated to be 224µM, the Vmax is estimated at 0.0278 molecules per
min. Also plotted are the theoretical kinetics calculated from these parameters
(black line).
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5.8 Mass spectrometry
In order to test that indeed the active serine is inhibited by covalent linking to
AEBSF, I decided to perform mass spectrometry experiments. For this purpose
2cfm v12 was incubated with 1mM AEBSF for at least one hour and thereafter
dialyzed in a large quantity of buffer that was exchanged at least once. The first
idea was to use tryptic digest followed by analysis of the digested fragments to
detect the mass shift of 183 Da resulting from AEBSF bound covalently to serine.
The actual mass spectrometry experiments were done by the proteome center in
Tu¨bingen. Although the experiments were repeated several times with both labeled
and unlabeled samples no significant differences could be detected. I decided to try
measurements of the undigested constructs, however, the fragments were too large
to be detectable on the spectrometer used.
Measurements with both the labeled and unlabeled constructs were repeated
at the MALDI of Hubert Kalbacher at the University Tu¨bingen. While both the
labeled and unlabeled variants could be detected and seemed to fly nicely for their
size, the spectra obtained were too broad and noisy to see a mass shift as small as
the expected resulting from the AEBSF label.
In order to finally obtain a good spectrum from the unfragmented protein I send
samples of 2cfm v12 with and without AEBSF treatment to Anja Boumeester at
the university of Utrecht. Both samples were measured on an EMR orbitrap and
the spectra were send to us.
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peaks from untreated sample
Species Theoretical mass (Da) Experimental mass (Da) ∆ Mas (Da)
A Unknown 63795.9 ±0.9
B 2cfm v12 untreated 64485.8 64481.7 ± 1.0 -4.1
C Unknown 64547.0 ± 0.4
peaks from sample treated with AEBSF
Species Theoretical mass (Da) Experimental mass (Da) ∆ Mass (Da)
A 2CFM V1/2 64485.8 64485.7 ± 0.2 -0.1
B 2cfm v12 + 1 AEBSF 64668.8 64666.2 ± 0.4 -2.6
C 2cfm v12 + 2 AEBSF 64851.8 64850.2 ± 0.9 -1.6
D 2cfm v12 + 3 AEBSF 65034.8 65032.6 ± 0.5 -2.2
E 2cfm v12 + 4 AEBSF 65217.8 65215.8 ± 0.9 -2.0
F 2cfm v12 + 5 AEBSF 65400.8 65399.7 ± 1.0 -1.1
G 2cfm v12 + 6 AEBSF 65583.8 65582.4 ± 1.0 -1.4
H 2cfm v12 + 7 AEBSF 65766.8 65765.4 ± 0.4 -1.4
I 2cfm v12 + 8 AEBSF 65949.8 65948.9 ± 0.7 -0.9
J 2cfm v12 + 9 AEBSF 66132.8 66131.9 ± 0.5 -0.9
K 2cfm v12 + 10 AEBSF 66315.8 66315.1 ± 0.5 -0.7
L 2cfm v12 + 11 AEBSF 66498.8 66499.3 ± 1.0 0.5
M 2cfm v12 + 12 AEBSF 66681.8 66681.3 ± 0.1 -0.5
Table 5.2: Peaks from the spectrum of the untreated and inhibited 2cfm v12. Data
provided by the University Utrecht.
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Figure 5.12: Spectra of the native and the inhibited 2cfm v12 taken with an EMR
orbitrap. The inhibited sample on the right shows different mass shifts, which
correspond to the masses of multiple copies of AEBSF attached to the protein.
Quite remarkably it seemed that up to twelve copies of AEBSF bound to the
inhibited 2cfm v12 (see figures 5.2 and 5.12). Since the mass shift of AEBSF bound
covalently is about 10 Da smaller than that of free AEBSF, it seems as if indeed
twelve serines were labeled covalently. While the variant has ample serines to explain
this massive labeling, sulfonyl fluorides should not be able to activate non-activated
serines close to neutral pH [57]. In the future, we therefore want to repeat the
tryptic digest experiments in Utrecht and try to localize the labeling sites.
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5.9 Crystal structure
Several crystallization screens were set up with the 2cfm v12 construct both alone
and with AEBSF or ApNA in the mixture. Only one condition formed crystals
after a microseeding experiment and only in the pure protein mixture. Spectra
were recorded at the PXII, SLS. Molecular replacement was challenging and was
initially carried out with the backbone of 2cfm. Both phasing and autobuild lead
to incomplete solutions in the beginning. I therefore iterated a circle of phasing
with the latest solution, autobuild, manual building and refinements several times.
After a satisfying solution was found I started refining the structure. After the first
phasing was successful, in the end a structure could be solved with a resolution of
2.6A˚, (see table 5.3) showing 2cfm v12 to be present in an open conformation with
two copies forming a dimer and the triad being torn apart (compare figure 5.13).
Since prior runs of gel filtration showed only a monomeric species present I decided
to investigate whether maybe short lived dimers could be observed in solution.
Wavelength (A˚) 0.97796
Resolution range (A˚) 46.01 - 2.593 (2.686 - 2.593)
Space group P 42 21 2 / 94
Unit cell 146.05 146.05 73.91 90 90 90
Unique reflections 25033 (2399)
Completeness (%) 99.79 (97.88)
Mean I/sigma(I) 11.98 (2.27)
Wilson B-factor 48.19
R-work 0.2140 (0.2941)
R-free 0.2687 (0.3665)
Table 5.3: Properties of the crystal structure obtained from 2cfm v12
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Figure 5.13: Structure of 2cfm v12 with two copies interacting with another. The
balls represent the insertion sites of the catalytic triad, with the histidine and as-
partate close to each other but the serine quite distant due to the two interlocked
copies.
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5.10 Multi angle light scattering(MALS)
In order to test whether 2cfm might form short-lived dimers in solution similar to the
ones observed in the crystal structure multi angle laser light scattering experiments
were set up.
Purified protein of 2cfm v1/2 was split into two aliquots, one of which was
treated with AEBSF. Both were separately run over a S75 analytical gel filtration
column immediately followed by MALS measurements of the filtered flowthrough.
In both cases only one diffracting species with an estimated mass corresponding
to the monomer could be detected, leading to the conclusion that also short lived
dimers are not formed in solution (see figure 5.14).
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Figure 5.14: (a) MALS measurement of untreated 2cfm var12. The second peak
is caused due to the equilibration of the column and is visible at every new mea-
surement according to the operator. The measurement shows a single peak wit an
estimated average particle size of 65 kDa, coinciding with the size of 2cfm. (b)MALS
measurement of 2cfm var12 inhibited with AEBSF. The measurement shows a single
peak with an estimated average particle size of 65 kDa, coinciding with the size of
2cfm. Measurement taken with Stefan Gru¨ner on a Wyatt miniDAWN TREOS at
658nm.
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Conclusion
The only active variant so far, 2cfm, is quite challenging. Although activity seems to
depend on all members of the catalytic triad, it is hard to get any direct evidence that
the enzymatic mechanism mirrors that of natural serine proteases and the design
goal is therefore met. One inherent problem of the host scaffold is its large size, that
makes a variety of experiments such as structure determinition by NMR unfeasible
and due to the complex arrangement of three domains makes other experiments such
as crystallography more likely to fail.
Since there are only two domains which carry the designed triad and the first
domain which interlocks with another copy of the protein in the crystal structure is
also unlikely to interact with the bound substrate, one of the next steps would be to
express the protein without the first domain and repeat the enzymatic assays and
crystallization.
However one of the earlier and quite small designs was also reevaluated and used
for additional designs with some unique properties.
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5.11 Guiding computational design into new di-
rections
Manual redesign of the 3N8M insertion site
The insertion site into 3N8M revealed some major problems. In general, the triads
sidechains were not able to come close enough to each other to create a functional
geometry. Since the protein itself is quite small and the placement of aspartate and
histidine was good relative to each other I tried a manual redesign and evaluated it
computationally.
With the current placement of histidine and aspartate, it was impossible to
find a suitable position for the serine. I therefore permuted the histidine and the
aspartate. The favorable geometry of histidine to aspartate stays mainly intact after
the permutation and I started looking for insertion sites for serine close to the new
histidine position.
One suitable position was found for serine, however this new insertion site favors
a geometry where the histidine ring is flipped, inverting the roles of the nitrogens in
the indole ring. I decided to do designs with Rosetta 3.5 for both orientations and at
the same side look into the feasibility of a catalytic triad with an inverted histidine.
Based on the resulting structures, designs were chosen together with Marcel Conrady
from the University of Tu¨bingen. He will continue with this project in his bachelor
thesis.
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Inverting the Histidine ring
Since the indole ring of histidine has two nitrogen atoms and both can be proto-
nated, there are two different tautomers in solution. Although the tautomer with
the protonated N-1 is preferred, it should be possible to also create proteases with
an inverted histidine where the N-1 interacts with the serine while the protonated
N-3 forms a hydrogen bond with the aspartate. Since the same insertion site of his-
tidine leads to geometrically different placements of the remaining catalytic residues
when different tautomers are used, this could not only be a chemically interesting
alternative but also increase the amount of possible insertion sites.
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Figure 5.15: The two different tautomers of the indole ring in histidine. The tran-
sition between the two tautomers is rapid at lower pH and slows down rapidly with
a pH of 9.
If the transition between the tautomers is fast (this is the case at low pH), only
a single peak should be visible in NMR at a quite unique position (12ppm on the
proton and 200ppm on the nitrogen scale). With a lower transition (at high pH),
these should separate into two peaks that differ on the nitrogen scale. Since usually
spectra are not recorded down to 200ppm, I decided to start NMR measurements
to see whether I can observe them. In a first NMR experiments with N15-labeled
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ubiquitin no peaks were visible, which might be due to the fact that the only histidine
in ubiquitin is quite close to the C terminus. It will, however, be interesting to repeat
the experiments with the new variants and try to find a pH and temperature where
both peaks are visible in order to be able to determine which orientation of the
histidine ring is dominating.
5.12 Discussion
Although the goal to introduce catalytic activity into a host scaffold seems to be
accomplished with the 2cfm v12 variant, the proof that indeed the catalytic triad
is responsible for this activity and the catalytic mechanism works as intended is
difficult to make. Different approaches to measure the inhibition of the active serine
with mass spectrometry were inconclusive, spectra of the unfragmented protein show
multiple bound inhibitor molecules. Further experiments with fragmentation of the
construct are needed to give insight into the binding sites of the inhibitor.
Thus far, only one set of crystals formed without any additional compounds
present. Attempts to co-crystallize the construct with either the substrate or in-
hibitor were unsuccessful. The resulting structure shows that the protein is present
in an open form with the catalytic triad torn apart. This is likely the result of in-
teractions with a second copy of 2cfm v12. In solution no dimers could be detected
with gel filtration or multi angle light scattering.
On the other hand a new generation of designs in a manually adapted insertion
site in the 3N8M scaffold is about to be tested, which also features a reversed indole
ring and according to the designs have better energies and a lower flexibility than
prior designs.
124 CHAPTER 5. RATIONAL DESIGN OF A NEW PROTEASE
Publications
Feldmeier K and Ho¨cker B (2013). Computational protein design of
ligand binding and catalysis. Current Opinion in Chemical Biology, 17(6),
929-933 [21]
The review was planned and written together with Birte Ho¨ecker.
Stiel A, Feldmeier K and Ho¨cker B (2014). Identification of Protein
Scaffolds for Enzyme Design Using Scaffold Selection. Methods in Molec-
ular Biology, 2014, 1216(1999), 117-128 [55]
This review was planned and written together with Andre Stiel and Birte Ho¨ecker.
Huang P∗, Feldmeier K∗, Parmeggiani F, Fernandez A, Ho¨cker B &
Baker D (2016). De novo design of a four-fold symmetric TIM-barrel
protein with atomic-level accuracy. Nature Chemical Biology, 12, 29-
34 [1] ∗ Equal contribution
The Design was planned together with all authors involved. I characterized most
of the variants described in the publication including techniques such as gel filtra-
tions, CD spectra and melting point analysis, Trp fluorescence and NMR. For the
successful design I additionally performed chemical unfolding studies and derived
∆G values, determined the non-formation of the disulfide bonds designed, set up
crystallization screens (the pipetting robot was operated by Sooruban Shanmugarat-
nam), took crystal spectra at the SLS and solved the structure now published as
5BVL. Together with Birte Ho¨cker I looked into the relation to other TIM-barrels,
made HHsearch comparisons and created a cluster map of sTIM11 with other mem-
bers of the TIM-barrel fold.
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